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 ABSTRACT 
Bringing Cyclopropenium to Life 
Spencer D. Brucks 
 
Burgeoning fields of nanomedicine and theranostics are propelled forward by the creative and 
systematic design of synthetic polymers. Cationic polyelectrolytes, comprising covalently-linked 
cations within each repeat unit, have drawn particular interest for their ability to bind nucleic 
acids and permeate cell membranes. Expanding the design space of these systems, we introduced 
a new family of polyelectrolytes based on the carbon-centered cyclopropenium cation. 
Cyclopropenium is a modular, aromatic building block with unique structural and electronic 
properties and, when coupled with modern living polymerization techniques, can be incorporated 
into macromolecules with precise size, shape, and composition. This thesis describes the 
translation of cationic polyelectrolytes based on cyclopropenium to biomedical applications and 
is structured into three parts. The first part evaluates cyclopropenium polymers as candidate non-
viral vectors for gene therapy and demonstrates that some derivatives are both biocompatible and 
efficacious transfection agents. In the second part, nanoparticles comprising cyclopropenium are 
exploited as live-cell image contrast agents and evolved into potentially theranostic tools. The 
final part describes a facile route to a novel class of cyclopropenium-based polymers. Together, 
this thesis illustrates that cyclopropenium is a versatile component of polyelectrolytes, poised to 
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[This introduction is based in part on the following publications: Nat. Commun. 2015, 6, 5950;  
Angew. Chem. Int. Ed. 2016, 55, 40, 12382; Macromolecules 2015, 48, 8, 2519] 
 Natural polymers are essential to all forms of life. DNA, composed of only four nucleotide 
monomers, is the universal genetic code across all three domains of life: Bacteria, Archaea, and 
Eukarya. Sugars are the most abundant biomolecules on earth and they are all built from covalently 
linked monosaccharide monomers.1 And, just twenty canonical amino acids, when connected 
through amide bonds, serve as the building blocks for all proteins. Collectively, it is polymeric 
structures that are responsible for the defining features of life: from the assembly of membranes 
and cytoskeletons to communication, motility, metabolism, and replication. Nature is able to 
accomplish this immense array of functions by assembling its polymers with unrivaled precision.2 
 By contrast, synthetic polymers have historically been derided as crude, impure, and not 
worthy of academic study. Polymers were chiefly synthesized through vulcanization, an 
uncontrolled process involving extensive heating in the presence of sulfur, until a stiff gel formed. 
Synthetic polymers were the domain of rubbers and resins, understood as colloidal clusters of 
small molecules, with unknown molecular weights. Less than a century ago, Staudinger was 
mocked for suggesting that a covalently bonded polymer could even exist. Relegated to the realm 
of industrial process, synthetic polymers were considered greasy and anything but precise.3,4  
 The development of living polymerization techniques over the past half-century has begun 
to erode this notion. Whereas traditional polymerizations are chaotic processes with growth, 
termination, and chain-transfer all happening simultaneously, living polymerizations are 
characterized by equivalent growth across all chains in the absence of irreversible termination or 
chain transfer processes. This produces polymers where the degree of polymerization increases 
linearly with conversion of monomers permitting molecular weights to be both controlled and 
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predicted. These strategies, including Ziegler-Natta olefin polymerization, ring-opening 
metathesis polymerization, and reversible-deactivation radical polymerizations, have enabled the 
design of macromolecules with precise size, shape, and composition.2,5–7  
 Ready access to well-defined macromolecules has inspired researchers to imagine what 
synthetic polymers can offer biology. With the development of robust and modular polymerization 
techniques suddenly synthetic polymers are no longer crude aggregates but are predictably tunable 
with immense chemical diversity.8 While nature’s palette of monomers is fairly limited in scope, 
synthetic chemists are predominantly limited by their imaginations. As Grubbs and Grubbs 
recently wrote, now “allow almost any sentient creature with access to a fume hood and an inert 
gas tank [can] make a vast range of polymers”.5 This accessibility and chemical diversity have led 
scientists to appreciate the role synthetic polymers can serve in biological systems. Burgeoning 
fields of nanomedicine and theranostics are propelled forward by the creative and rational design 
of synthetic polymers with varied composition, architecture, and functionality.6,9–12 
 An emergent class of polymers that has drawn particular interest is cationic 
polyelectrolytes. Comprising a covalently-linked cation with an electrostatically associated anion 
at each repeat unit, cationic polyelectrolytes introduce a novel design element into the polymer 
scaffold. Rational engineering of these systems has been exploited in a range of biomedical 
applications. The embedded positive charge can rapidly complex and package anionic nucleic 
acids through entropic displacement of its counterion, motivating study of these materials as gene 
delivery vectors. Additionally, the cationic unit promotes cell adhesion and uptake affording a 
platform to enter, diagnose, and treat live cells.13–16 
 Heretofore, most functional units investigated for cationic polyelectrolytes have been 
heteroatom based, with polymers containing phosphonium,17 ammonium,18 or imidazolium19 
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being particularly common (Figure 1). Polymers such as poly(L-lysine), poly(ethylenimine), and 
chitosan are also regularly employed but possess pH-dependent cations.20,21 While valuable, all of 
these systems are limited in their ability to tune physical properties. The principal strategies to 
modulate functionality are varying alkyl substituent chain length and spacer chemistry from the 
polymer backbone. Thus, the identification of new cationic polyelectrolytes with unique pathways 
to tune function is of high import.  
 We envisaged incorporating the carbon-centered cyclopropenium cation into 
polyelectrolytes as a non-conventional polymer building block. As the smallest Hückel aromatic, 
cyclopropenium possesses an unusually high degree of stability for a carbocation,22 which can be 
further enhanced via incorporation of amino substituents onto the ring (i.e. 
trisaminocyclopropenium).23,24 Consequently, trisaminocyclopropenium is uniquely both carbon-
centered and electron-rich with tunable amino substituents. These novel structural and electronic 
properties have already motivated the development of cyclopropenium ions as metal ligands,25 
organocatalysts,26 and fuel cell membranes27,28 and we hypothesized they could meaningfully 
expand the design space of available cationic polyelectrolytes as well.   
 Our vision for a cyclopropenium-based monomer included a polymerizable unit, a 








Variable spacer to polymer backbone
Tunable alkyl substituents
Figure 1. Structures of leading cationic 
polyelectrolytes. Common handles to modify 
chemical structure (blue) and tether to polymer 
backbone (orange) can be used to tune functionality. 
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modular handles to tune physical properties (Figure 2A). We elected to study styrenic derivatives 
as they are amenable to a wide range of reversible-deactivation radical polymerization strategies. 
Thus, we designed a styrene-based monomer and subsequently used reversible-addition 
fragmentation chain-transfer polymerization (RAFT) to assemble  homopolymers, statistical 
copolymers, and diblock copolymers of varying composition (Figure 2B). The specific details of 
the synthesis have been described elsewhere,29 but this route importantly furnished a library of 
linear cyclopropenium polymers of varying composition and hydrophilicity. We further 
recognized that our monomer was amphiphilic and thus could serve as a polymerizable surfactant 
in an emulsion polymerization to form nanoparticles (vide infra).   
Figure 2. The cyclopropenium cation as a non-conventional polymer building block. (a) Schematic 
design of polymerizable cyclopropenium-based monomer. (b) The styrenic cyclopropenium monomer can 
be employed in reversible-deactivation radical polymerization (RDRP) to yield homopolymers, block 
copolymers, and statistical copolymers, or in emulsion polymerization to yield nanoparticles.  
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What truly unlocked the chemistry of linear cyclopropenium polymers however, was the 
development of a post-polymerization functionalization strategy. Due to the cationic nature of the 
cyclopropenium groups, our first library of synthesized polymers could not be characterized by 
size exclusion chromatography. This limitation on our understanding of molecular weight and 
dispersity hampered our ability to make direct comparisons between different polymers. Thus, we 
developed a route to cyclopropenium-based polymers from a well-characterized neutral precursor 
polymer (Figure 3). A one-step post-polymerization click reaction quantitatively converted either 
pendent or main-chain secondary amines to trisaminocyclopropenium rings. With the specific 
details of the reaction described elsewhere,29 this robust transformation enabled precise structure-
property relationship studies across a family of cyclopropenium-based polymers while holding 
effects of dispersity and degree of polymerization constant.  
 Concomitantly, we investigated synthetic strategies to develop cationic surface-charged 
nanoparticles using cyclopropenium monomers and block copolymers via surfactant-free emulsion 
Figure 3. Synthesis of cyclopropenium-based polymers can be accomplished either through reversible-
deactivation radical polymerization (RDRP) of a cyclopropenium-based monomer or through a post-
polymerization functionalization (PPF) coupling a cyclopropenium chloride to a neutral parent polymer. 
The neutral polymer can be composed of either main-chain or pendent secondary amines in either a 
homopolymer or block copolymer. The cyclopropenium salt tolerates a variety of amino substituents.  
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polymerization. Both monomers and block copolymers were found to stabilize oil-in-water 
emulsions as functional surfactants where the diameter of the resultant nanoparticle could be 
reliably tuned from 30-100 nm with narrow dispersity (Figure 4). Simply increasing the percent 
loading of  surfactant increased the surface-to-volume ratio and decreased particle size. 
Additionally, as cyclopropenium is a remarkably stably cation,23 these nanoparticles were found 
to retain their highly positive surface charge for the pH range of 1.4 to 12.6. The ability of 
cyclopropenium-containing molecules to stabilize a nanoparticle interface eliminates the need for 
additional surfactants, solvents, or multi-step protocols, highlighting their potential in biological, 
imaging, and industrial applications.  
  
 This thesis describes our first studies of this family of cyclopropenium-based polymers and 
nanoparticles for biomedical applications. The first part describes our efforts evaluating 
cyclopropenium-based polymers as candidate non-viral vectors for gene delivery. In the second 
part, we show how the nanoparticles can be exploited as live-cell image contrast agents and 
potentially theranostic tools. In the final part, we briefly describe a new project developing a novel 
class of cyclopropenium-based polymers. Collectively, this thesis illustrates the different avenues 
through which we have brought cyclopropenium-centered cationic polyelectrolytes to life.  
Figure 4. Illustrated representation of the surfactant-free emulsion 
polymerization of (a) cyclopropenium-based monomers and (b) 
cyclopropenium-containing block copolymers to form surface-charged 
polymer nanoparticles.  
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CYCLOPROPENIUM POLYMERS FOR GENE DELIVERY 
[This section is based on the following publications: Angew. Chem. Int. Ed. 2016, 55, 40, 12382; 
Polymers 2017, 9, 79; J. Polym. Sci. A Polym. Chem. 2017, 55, 19, 3167] 
 Gene therapy, the process by which exogenous genetic information is brought into cells by 
a delivery vector to impart a therapeutic effect, has captivated generations of scientists for its 
potential to treat genetic diseases and cancers.1 The tantalizing vision of a single outpatient 
treatment to cure hemophilia, blood cancers, or hereditary blindness amongst many other disorders 
has motivated research for decades. After a tragic setback in the late 1990s gene therapy appeared 
to be on the brink of failure, but sustained efforts have driven significant progress in the past 
several years.2,3 Over 2000 of clinical trials have been conducted in the last decade and just this 
year the US Food and Drug Administration approved Luxturna as the first gene therapy for an 
inherited genetic disorder.4,5 However, the full potential of gene therapy remains unrealized. 
Today, the fundamental challenge of gene therapy is the design of efficient, biocompatible 
delivery vectors.4,6,7 Since the concept of gene delivery was first introduced, both viral and non-
viral options have been explored, with each presenting their own benefits and drawbacks.8 Though 
viruses have evolved over billions of years to efficiently deliver their DNA, the clinical translation 
of modified viral technologies has been limited by immunogenicity, lack of selectivity, and 
production difficulties.6,9 On the contrary, synthetic non-viral vectors elicit a reduced 
immunogenic response and are generally much more facile to produce, but thus far have yielded 
lower delivery efficiencies. The development of an optimized non-viral vector, balancing clinical 
safety with high efficiency, thus remains the critical goal to the realization of gene therapy.10  
Cationic polymers are one of the most commonly studied non-viral vectors due to their 
high stability and capacity to tune macromolecular composition and structure via robust 
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chemistry.11,12 Crucially, the positive charge embedded in each monomer unit promotes rapid 
complexation with the negatively charged phosphate backbone of nucleic acids into a polyplex, 
which can mediate cell adhesion and uptake. To yield efficient cellular transfection, polyplexes 
must overcome a host of obstacles and barriers both outside and inside the cell. An ideal gene 
delivery vector must be engineered to localize at the cells of interest, permeate cell membranes, 
and escape the endosome by either membrane lysing or the proton sponge effect, while shielding 
their nucleic acid cargo from degradation and not provoking an immunogenic response (Figure 
1).13,14 Linear poly(ethylenimine) (PEI) was the first cationic polymer observed to rapidly bind 
nucleic acids into polyplexes via electrostatic interactions and has since become an industry 
standard non-viral vector.15 In the subsequent years, there has been a great proliferation of cationic 
structures shown to bind and transfect nucleic acids.16–18 In addition to increasing the library of 
cationic polymers available, these research efforts have begun to uncover some design principles 
towards optimizing polymeric structure for transfection. In general, it has been shown that 
transfection efficiency and cytotoxicity trend with molecular weight and the degree of polymer 
chain branching.19–22 With the advent of reversible-deactivation radical polymerization techniques, 
the challenge has now become fine-tuning polymer composition and architecture to probe detailed 
structure-property relationships among the various polymers accessible.23  
 Our report detailing the functionalization of polymers with an array of 
bis(dialkylamino)cyclopropenium chloride (BACCl) derivatives affords an ideal modular platform 
from which to study polymers for gene delivery. In the efficient post-polymerization click reaction, 
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polymers bearing either pendent or main-chain secondary amines were quantitatively transformed 
into the aromatic trisaminocyclopropenium (TAC) ion. This rapid reaction furnishes well-defined 
polyelectrolytes, where effects of dispersity and degree of polymerization are held constant, 
enabling precise structure-property relationship studies.  
To determine whether this transformation was relevant for gene delivery we focused on the 
TAC homopolymers that were highly water-soluble. Furthermore, to streamline comparisons 
between materials we elected to change only subtle elements of the TAC structure, functionalizing 
Figure 1. Transfection via a non-viral gene delivery vector. Polyplexes comprising 
nucleic acids (e.g. DNA) and a polyelectrolyte non-viral vector must enter the cell 
(typically through endocytosis), escape the endosome via either lysing of the endosomal 
membrane or the proton sponge effect, and release its genetic cargo for nuclear uptake. 
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with either a morpholine (Mo) or piperidine (Pep) substituent, on two different polymer backbones, 
PEI and poly(methylaminostyrene) (PMAS) (SI Figure 1). Cytotoxicity assays and luciferase 
transfection experiments in HEK-293T cells revealed a significant dependence on the chemical 
structure of the pendent TAC ion, namely on its amino substituents, and on the identity of the 
polymer backbones. All four TAC polymers showed a similar toxicity profile to linear PEI (25 kg 
mol
-1
) at low dosages. However, at high loadings, polyTACs were found to be more biocompatible, 
especially those bearing a styrene backbone (Figure 2). Functionalizing PEI with TAC(Mo) 
endowed the polymer with low toxicity, affording a cell viability of approximately 50% at both 50 
and 100 µg mL
-1
 loadings.   
Figure 2. Biocompatibility of TAC-functionalized polymers at various doses in HEK-293T cells 
following 48 h incubation. Viability is measured by trypan blue dye exclusion and normalized to 
untreated cells. Error bars show the standard deviation of triplicate measurement. 
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 While structural modification of PEI with TAC ions led to a lower transfection efficacy 
compared to the parent polymer (Figure 3), comparing the two modified PEI materials bearing 
TAC(Pep) and TAC(Mo) showed notable differences in transfection efficiency. These two 
materials exclusively differ in the chemistry at the 4-position of the six-membered ring: a simple 
variation between a methylene group and an ether oxygen. The PEI(Pep) polyplexes transfected 
cells almost as well as the PEI parent polymer, but polyplexes of PEI(Mo) exhibited poor 
transfection efficiency. Potentially, this difference may be attributed to the increased 
hydrophobicity of PEI(Pep) over PEI(Mo), a property that has been shown to play a key role in 
non-viral vectors.24–28 Polyplexes of PEI and TAC polymers with plasmid DNA (pDNA), at their 
most efficient loadings (noted in Figure 3), were further characterized by dynamic light scattering 
for hydrodynamic diameter (DH) and zeta potential (ζ; SI Table 1). Since the DH and surface charge 
values are similar for PEI(Pep), PEI(Mo), and unfunctionalized PEI polyplexes, the observed 
discrepancy in transfection efficacy may be due to fine structural variations between each agent. 
As cyclopropenium is a permanent positive charge and contains no basic amines to protonate, 
polyplexes likely escape the endosome via membrane lysing rather than a proton sponge 
mechanism,29 further suggesting that subtle changes in hydrophobicity have an enormous impact 




 Changing the polymer backbone from PEI to PMAS resulted in smaller polyplexes that 
were also viable, efficacious transfection agents [Figure 3 and SI Figure 2, PMAS(Pep) and 
PMAS(Mo)]. All of our most effective formulations are within the size regime that Zhou and 
coworkers outlined for high-efficiency transfection reagents, that is, less than 500 nm.30  
Furthermore, the PMAS-based materials exhibited optimal pDNA transfection at lower charge 
ratios than PEI and PEI(R) polymers indicating a more efficient electrostatic binding (SI Table 1). 
Within the range of the error bars, the more hydrophobic PMAS(Pep) derivative and the 
Figure 3. Luciferase expression in HEK-293T cells transfected with pDNA containing the firefly 
luciferase reporter gene using TAC polymers and 25 k linear PEI. Polymer backbones are noted in white 
boxes with amino substituents pictured above the respective bars. Luciferase expression is measured after 
48 h incubation with specified polymer loadings (all with pDNA loading of 3 µg mL-1) and normalized by 
cell count. Error bars show the standard deviation of triplicate measurement. 
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PMAS(Mo) derivative show similar efficacy, unlike in the PEI systems. These results suggest that 
our post-polymerization functionalization reaction with BACCl groups has great potential as a 
platform to tune the chemical composition of TAC-based polyelectrolytes, build detailed structure-
property relationships, and inform design principles for the optimization of transfection agents.   
 We next extended these results by probing the effect of the substituted alkylamino chain’s 
degree of branching on cytotoxicity and transfection efficacy. Pendent moieties have been shown 
to modify the structure and stability of polymer-DNA polyplexes to facilitate cellular release, with 
several reports exploring the effects of fine tuning a substituent alkyl chain length.31–33 However, 
comparably few studies have investigated the nature of branching within an alkyl group and its 
effect on transfection efficacy. As our cyclopropenium platform is amenable to a wide variety of 
BACCl derivatives, we synthesized two more to directly compare the branching of the alkyl chain: 
n-butyl (Bu; BACBu) and isopropyl (iP; BACiP). These two BACCl structures differ in the degree 
of branching, and thereby “floppiness”, as well as hydrophobicity, as the Bu derivative has one 
additional carbon. We again functionalized these derivatives on both PEI and PMAS polymer 
backbones furnishing a total of four additional candidate non-viral vectors.  
All four homopolymers were highly water-soluble, permitting their condensation with an 
aqueous solution of pDNA containing the firefly luciferase reporter gene. Combining the polymers 
at varied loadings with a fixed amount of pDNA, and subsequently incubating in HEK-293T cells 
for 48 h, revealed the polymers’ biocompatibility as a function of loading. We found that PEI(iP) 
and PMAS(Bu) were the most biocompatible with high cell viabilities through loadings of 20 µg 
mL
-1
 (Figure 4). Surprisingly, their counterparts, PEI(Bu) and PMAS(iP), exhibited notable 
toxicity at all loadings tested. All TAC-derived polymers in this study were highly toxic at loadings 
of 50 µg mL
-1
 and greater, similar to linear PEI. This stands in contrast to the work described 
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earlier with the more rigid piperidine or morpholine substituents which were still viable in this 
regime. Thus, rigidity or flexibility of substituent chains stands as an important parameter to 
understand optimal gene transfection. Taken together, our results suggest there is a complex 
interaction between a polymer backbone and its substituent in the design of biocompatible gene 
delivery vectors. 
We further found that this fine tuning of the substituent chain branching had a dramatic 
influence on delivery efficacy. In order to assess the amount of polymer necessary to completely 
condense pDNA into a polyplex gel electrophoresis shift assays were performed (SI Figures 3-6). 
While all polymers were able to fully bind the pDNA by a weight ratio of 3.33 polymer : 1 pDNA, 
PEI(iP) was the most efficient, binding at a weight ratio of only 0.83 polymer : 1 pDNA. This 
corresponds to the lowest polymer loading tested for either biocompatibility or transfection and 
Figure 4. Biocompatibility of TAC-based polymers at various doses in HEK-293T cells following 48 h 
incubation. Viability is measured by trypan blue dye exclusion and normalized to untreated cells. Error 
bars show the standard deviation of triplicate measurement. 
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less than 1 TAC unit per phosphate anion of pDNA (SI Tables 2-3). However, binding efficiency 
is not a clear indicator of delivery efficiency, as too favorable an interaction can be detrimental for 
eventual release of the genetic material.34–36  
Luciferase expression assays revealed a significant dependence on the nature of the amino 
substituent and polymer backbone for successful gene delivery. While all TAC-based polymers 
transfected pDNA significantly better than the untreated controls, PMAS(iP) demonstrated the 
highest transfection efficacy (Figure 5). As is the case with unmodified linear PEI, successful 
delivery of intact pDNA to cells comes at the cost of significant cytotoxicity. By contrast, the 
nontoxic PEI(iP) demonstrated a much lower luciferase activity. Interestingly, PEI(iP) was the 
most efficient at compacting pDNA into a polyplex, suggesting that it binds nucleic acids too 
strongly and never releases its payload. Transforming either of the polymer backbones with 
TAC(Bu) seemed to yield successful non-viral vectors capable of both binding and slowly 
releasing pDNA. This could potentially be attributed to critical destabilization of the cell and 
endosomal membranes due to the long, flexible alkyl substituents. At their optimal loadings, both 
PEI(Bu) and PMAS(Bu) demonstrated two orders-of-magnitude transfection improvement over 
untreated control cells. Combined with the cytotoxicity and pDNA-binding data, we conclude that 
amongst this set of TAC polymers, PMAS(Bu) is the most potent non-viral vector.  
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Our results demonstrate that there is an important interplay between polymer backbone and 
substituent structure, and that both must be carefully considered in the design of non-viral vectors. 
While hydrophobic modifications of non-viral vectors are frequently reported to promote 
transfection, our data indicate that a careful balance of hydrophobicity and substituent flexibility 
must be achieved for optimal gene delivery. The drastic differences in transfection efficiency 
deriving from minor structural variations showcases the need for synthetic strategies to modularly 
access a wide variety of structures. Importantly, our work exemplifies that design of transfection 
reagents demands precise control over all aspects of polymer structure and highlights the necessity 
of a robust, modular platform from which to study them. 
  
Figure 5. Luciferase expression in HEK-293T cells transfected with pDNA containing the firefly 
luciferase reporter gene using TAC polymers and 25 k linear PEI. Luciferase expression is measured after 
48 h incubation with specified polymer loadings (all with pDNA loadings of 3 µg mL-1) and normalized 
by cell count. Error bars show the standard deviation of triplicate measurement.  
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MODULATING POLYMER ARCHITECTURE FOR ENHANCED TRANSFECTION 
The singular challenge in the design of gene delivery vectors is understanding how tunable 
elements of polymer composition and architecture affect macroscopic properties, including 
biocompatibility and transfection efficacy. Equipped with a modular platform to synthesize 
cyclopropenium-based polymers, the question for us became which structural features to tune. 
Having already explored how the chemistry of the monomer and atom-level manipulations therein 
could affect transfection, we were inspired to study the role three-dimensional arrangement of the 
same monomers would play. Specifically, we were interested in how multivalent presentation of 
cyclopropenium units may affect their gene delivery capabilities, and thus designed both brush and 
star polymers. 
Brush and star polymers have a three-dimensional architecture with multiple terminal 
groups that has motivated their recent syntheses and applications as non-viral gene delivery 
vectors.37,38 Wang and co-workers have led efforts demonstrating the superior efficacy of polymers 
with such multivalencies, reporting over 8000-fold enhancements in transfection efficiency 
compared to linear analogues.39,40 These enhancements are attributed to multiple sources: an 
improved interaction of polymers with DNA to form a polyplex; increased cellular uptake due to 
higher likelihood of electrostatic interactions with cell membrane; and, enhanced protection of 
DNA from enzymatic degradation.39,41 While with linear polymers it is generally understood that 
increasing molecular weight increases both transfection efficiency and cytotoxicity, this effect is 
lessened in brush polymers where it has been shown that distributing mass across multiple side-
chains attenuates the cytotoxicity.38 
Though it has only been 15 years since the first star-shaped polymer was investigated for 
transfection, they have also emerged as one of the most promising classes of non-viral gene 
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delivery vectors.42 Star polymers, with multiple chains, or arms, functionalized onto a single core, 
show a higher degree of flexibility than dendritic or other branched polymers, that may be 
important in the condensation of DNA. Though star polymers have demonstrated a similar trend 
to their linear analogues, where increasing the molecular weight of the arms increases cytotoxicity, 
this effect can be mitigated by increasing the number of arms.38,43,44 Keeping the molecular weight 
constant and increasing the number of arms has been shown to decrease cytotoxicity across a 
number of different functionalities.42,43,45 Thus, we were motivated to study if these same 
architecturally-based transfection enhancements would be borne out in second-generation 
cyclopropenium polymers. 
For these studies, it is essential that the synthesized polymers have well-defined structures 
and narrow dispersities. Considering brushes first, we designed a synthetic route that exploited 
two orthogonal living polymerization techniques, atom-transfer radical polymerization (ATRP) 
and ring-opening metathesis polymerization (ROMP), to provide robust control over degree of 
polymerization in two dimensions (Figure 6). ATRP was employed to synthesize the side chain, 
ultimately dictating the number of cyclopropenium units per branch, while ROMP was used to 
polymerize the backbone, controlling the number of side chains.  
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  Furthermore, brush polymers can be stitched together by one of three methods, “grafting 
from”, “grafting onto”, and “grafting through”, which each present advantages and 
disadvantages.46,47 Easily the most common, the “grafting from” approach involves the 
straightforward polymerization of side-chains from a synthesized backbone but is limited by the 
density of initiation sites. In the “grafting onto” approach, side chains and backbone are 
synthesized separately and then coupled, but are restricted from high grafting densities due to steric 
hindrance. We decided to synthesize our brushes in a “grafting through” approach, which involves 
the design of functional side-chains (i.e. macromonomers) which can be subsequently polymerized 
into a brush. This approach guarantees complete backbone functionalization but can be difficult to 
achieve high degrees of backbone polymerization.46 There is an additional choice in 
macromonomer design regarding the incorporation of the polymerizable handle that Xia recently 
demonstrated as non-trivial. The authors found that growing the macromonomer and then 
subsequently coupling the polymerizable handle onto it led to lower polymer dispersities and 
reduced chain end coupling.48 Taking these insights into account, we designed a full synthesis for 
cyclopropenium-based brush polymers (Figure 7 and SI Figures 7-12).   
Figure 6. Orthogonal polymerization strategies, ATRP and ROMP, were employed to 














Our synthetic route begins with a prototypical ATRP of tert-butyl methyl(4-
vinylbenyzl)carbamate where the initiator contains an azide handle. This reaction proceeds rapidly 
and is performed at low monomer equivalents to afford short polymers (DP 15-25) of low 
dispersity (Đ < 1.10). These homopolymers are covalently linked with a norbornene handle via 
copper-catalyzed click chemistry (CuAAC) to yield the functional macromonomer. CuAAC 
optimization resulted in up to 90% of chain ends being functionalized as determined by 1H NMR 
(SI Figure 8). We found that the efficiency of this reaction decreased as molecular weight 
increased, which is corroborated by other reports that generate macromonomers weighing no more 
than 5 kDa.49,50 These macromonomers were then subjected to ROMP with Grubbs’ 3rd generation 
catalyst providing the desired brush architecture. As expected for a “graft through” approach, this 
reaction did not go to completion with small quantities of macromonomer still remaining (SI 
Figure 10). We have been attempting to purify these materials by extensive dialysis but are in the 
process of developing other purification strategies. These brushes are then fully deprotected and 
functionalized with cyclopropenium following a modified post-polymerization functionalization 
strategy. For complete deprotection to the secondary amine, we found it necessary to react with 
trifluoroacetic acid rather than trimethylsilyl chloride and quench with a weak base. The 
functionalization reaction with any BACCl proceeds rapidly at low molar equivalents as confirmed 
by 1H NMR, as previously described. Thus, in five sequential steps from monomers, we were able 
to synthesize cyclopropenium-based brush polymers. 
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Functionalized star polymers can be synthesized in fewer steps by either an “arm-first” or 
“core-first” approach.42 The “arm-first” strategy allows control over arm length but can retain 
linear precursors after conjugation to a central core. Additionally, synthesizing the arms of the star 
first lacks a robust route to control the number of arms ultimately attached. On the contrary, 
synthesizing star polymers “core-first” enables control over arm number and simplifies 
purification, but requires a multifunctional initiator. This poses a significant drawback because if 
multiple sites are simultaneously initiated they can radically couple leading to undesirable 
termination.51,52 Having been plagued by linear precursor contamination for brushes (i.e. unreacted 
macromonomers), we chose to synthesize cyclopropenium-based stars via a “core-first” approach.  
Starting from a commercially available tetra-functional ATRP initiator we synthesized star 


























































































































Figure 7. Synthetic scheme for cyclopropenium brush polymers. (i) CuBr, PMDETA, Anisole, 90 °C, 1-2 
h; (ii) CuBr, PMDETA, dry THF, 50 °C, 24 h; (iii) Grubbs 3rd cat., dry DMF, 35 °C, 12-18 h; (iv) 1. TFA, 
dry DCM, rt, 2 h 2. TEA; (v) BAC(Pep)Cl, CHCl3, DIPEA, 65 °C, 18 h.   
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and SI Figures 13-15). In order to eschew undesirable chain end coupling, we significantly 
lowered the loading of both CuI and the ligand to limit the number of sites initiated. Tuning the 
polymerization in this fashion furnished polymers with monomodal and narrow dispersities. From 
here, our modified deprotection and reported functionalization reactions were employed to unveil 
the secondary amine and subsequently conjugate a cyclopropenium salt. This modular approach 
to cyclopropenium-based star polymers is amenable to other valencies, such that the synthesis of 
3-arm and 6-arm should directly follow from the commercially available reagents.53  



























































































Figure 8. Synthetic scheme for cyclopropenium star polymers. (i) CuBr, PMDETA, Anisole, 90 °C, 12 h; 
(ii) 1. TFA, dry DCM, rt, 2 h 2. TEA; (iii) BAC(Pep)Cl, CHCl3, DIPEA, 65 °C, 6 h.  
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cyclopropenium-based brush and star polymers are ongoing. Based on literature results, we believe 
that the multivalent presentation of cyclopropenium units will improve upon our previously 
reported transfection results, but this has not yet been experimentally demonstrated. However, 
these modular synthetic routes meaningfully expand the landscape of cyclopropenium polymers 
and will allow divergent approaches in future application-driven studies. The capacity to 
synthesize brushes and stars in addition to linear polymers and nanoparticles can help launch 
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All materials were purchased from Sigma-Aldrich and used without further purification, except 
as noted below. Methylene chloride (CH2Cl2) and N,N-dimethylformamide (DMF) were dried 
using a J.C. Meyer solvent purification system. Eluents for column chromatography were HPLC 
grade and purchased from Fisher Scientific. Deuterated solvents used for NMR spectroscopy 
were purchased from Thermo Fisher Scientific. Organic solutions were concentrated with a 
Buchi rotary evaporator. Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum 
(FBS), and penicillin/streptomycin were purchased from Invitrogen. Spectrum Labs dialysis bags 
were purchased from VWR.  
NMR Spectroscopy 
1H NMR spectra were recorded on a Bruker Avance III 400 MHz spectrometer. Standard 
abbreviations indicating multiplicity were used as follows: s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet), b (broad). 
Cell culture 
HEK-293T cells (American Type Culture Collection) were grown in DMEM culture medium 
with L-glutamine supplemented with 10% v/v FBS (Atlanta Biologicals) and 1% v/v 
penicillin/streptomycin (Gibco). Cultures were incubated in humidified tissue incubators 
(Thermo Scientific) at 37°C and 5% CO2. 
Dynamic light scattering 
Polyplex size and zeta potential were measured on a Malvern Zetasizer Nano ZS (Malvern, 
United Kingdom). For all measurements, polyplexes were diluted 1:100 in Milli-Q water at 
neutral pH. The reported diameters are the average of three measurements, where each 
measurement comprises at least 10 acquisitions. The zeta potential was calculated according to 
the Smoluchowski approximation.  
Cell viability  
Trypan blue dye exclusion cell counting was performed in triplicate with an automated cell 
counter (ViCell, Beckman-Coulter). Cell viability under experimental conditions is the viable 
cell count reported as a percentage relative to untreated cells. 
Polyplex formation 
Solutions of polymer in RNase-free water were added to 3 µg of pDNA (gWiz-Luciferase; 
Aldevron, Fargo, ND) at specified loadings. The solutions were then vortexed at 1500 rpm for 3 
min at room temperature. 
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Cell Transfection and Luciferase Expression 
HEK-293T cells were seeded on 12-well plates at a density of 50,000 cells per well 24 hours 
prior to transfection. The media was then evacuated, replaced with fresh media, and 
supplemented with the polymer-DNA polyplexes. After 48 hours of incubation, cell viability was 
measured, and cells were re-plated on 96-well plates at a density of 10,000 cells per well and 
analyzed for luciferase activity according to the manufacturer’s protocol. Briefly, 24 hours after 
seeding, cells were rinsed with PBS and lysed with 20 µL/well 1X Cell Lysis Buffer (Promega, 
Madison, WI). To the cell lysates was added 100 µL/well of Luciferase Assay Reagent (Promega) 
and the light produced was quickly read on a plate reader (PerkinElmer, Waltham, MA) for 10 
sec per well. Results were expressed as relative light units (RLU) normalized to cell counts, with 
error bars representing the standard deviation from the triplicate measurement. 
Gel Electrophoresis Shift Assay 
Polyplexes were prepared at different weight ratios by adding 10 µL of polymer in Milli-Q H2O 
to 10 µL of pDNA (5 ng/µL), and vortexing at 1500 rpm for 3 min at room temperature. To the 
polyplex solution was then added 2 µL of loading dye, for a total volume of 22 µL, which was 
subsequently added to the well. Agarose gels were prepared as 1 wt% in tris-acetate EDTA (TAE) 
buffer with 2 µL ethidium bromide and run at 100 V for 20 min. Gels were visualized under UV 
illumination at 365 nm.  
Charge Ratio Calculation: (3 µg pDNA)*(MW per polymer repeat unit)
330 g per pDNA nucleotide
= Polymer mass for 1:1 charge ratio with pDNA 
 
Synthesis 




Synthesis of 2,3-Bis(dibutylamino)-1-cyclopropenone, 1 
This procedure was performed at ambient conditions. Dibutylamine (8 equiv) was slowly added 




















The solution turned orange, and was allowed to warm to room temperature with stirring 
overnight. The reaction mixture was washed 3 x 1 M HCl, 1 x deionized water, and 1 x brine 
before being dried over magnesium sulfate and concentrated under vacuum to yield a crude 
orange solid. The solid was dissolved in tert-butanol and to this was added 4M potassium 
hydroxide (aq). The solution was heated at 70 °C for 2 h, and then water was removed by rotary 
evaporation. The resulting solid was dissolved in CH2Cl2 and filtered to remove salt. The organic 
solution was dried with magnesium sulfate and re-concentrated under vacuum. The crude 
material was purified by column chromatography (100% EtOAc to 5% MeOH in CH2Cl2) to 
yield the title product as an orange solid (30% two-step yield). 1H NMR (400 MHz, CDCl3): δ 
3.16 (t, 8H), 1.59 (m, 8H), 1.34 (m, 8H), 0.94 (t, 12H). 
 
Synthesis of 1,2-Bis(dibutylamino)-3-chlorocyclopropenium chloride (BACBu), 2 
Oxalyl chloride (2 equiv) was slowly added to a solution of 1 (1 equiv) in dry CH2Cl2 at 0 °C 
under argon. The solution was allowed to warm to room temperature as the reaction proceeded 
for 1 h. The solution was then concentrated under vacuum to yield the title product as a brown 
liquid in quantitative yield.  1H NMR (400 MHz, CDCl3): δ 3.64 (t, 4H), 3.50 (t, 4H), 1.76 (m, 
4H), 1.66 (m, 4H), 1.40 (m, 8H), 0.99 (t, 12H). 
 
Synthesis of PMAS(Bu) 
 
This procedure was performed open to the atmosphere. Poly(methylaminostyrene) (PMAS; DP 
~50, 1 equiv amine monomer) was dissolved in CHCl3 in a scintillation vial equipped with a stir 
bar. To the vial was added N,N-diisopropylethylamine (3 equiv) and 2 (1.5 equiv) dissolved in 
CHCl3. The reaction was stirred at 65 °C for 3 h. The resulting solution was concentrated under 
vacuum, dissolved in minimal acetone and precipitated once into ethyl acetate at -78 °C. The 
precipitated powder was dissolved in methanol and transferred to a 3.5k MWCO Spectrum Labs 
dialysis bag and dialyzed against methanol followed by concentration under vacuum to yield a 
pale brown powder. 1H NMR (400 MHz, CDCl3): δ 7.18-6.07 (b, 200H), 4.99-4.39 (b, 100H), 
3.78-2.91 (b, 575H), 1.98-1.58 (b, 400H), 1.39-1.08 (b, 650H), 1.02-0.63 (b, 600H). 
 
Synthesis of PEI(Bu) 
 
This procedure was performed open to the atmosphere. Linear 25 k poly(ethylenimine) (DP ~581, 
1 equiv) was dissolved in CHCl3 in a scintillation vial equipped with a stir bar. To the vial was 
added N,N-diisopropylethylamine (3 equiv) and 2 (1.5 equiv) dissolved in CHCl3. The reaction 
was stirred at 65 °C for 3 h. The resulting solution was concentrated under vacuum, dissolved in 
minimal acetone and precipitated once into ethyl acetate at -78 °C. The precipitated powder was 
dissolved in methanol and transferred to a 3.5k MWCO Spectrum Labs dialysis bag and dialyzed 
against methanol followed by concentration under vacuum to yield a yellow-brown powder. 1H 
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NMR (400 MHz, CDCl3): δ 4.45-3.15 (b, 7000H), 1.71-1.55 (b, 3500H), 1.43-1.22 (b, 5400H), 
1.00-0.90 (b, 6200H).  
 
Procedures for the synthesis of cyclopropenium brush polymers 
 
 
Synthesis of N3-PBoc, 3 
Copper (I) bromide (0.5 equiv) was added to a dry Schlenk flask equipped with a stir bar and 
deoxygenated via three vacuum-argon cycles. Degassed tert-butyl methyl(4-
vinylbenzyl)carbamate (40 equiv) and degassed N,N,N’,N”,N”-pentamethyldiethylenetriamine 
(PMDETA; 0.5 equiv) were then added and allowed to stir for ten minutes to form copper 
complex. The mixture was then subjected to three freeze-pump-thaw cycles. The Schlenk flask 
was closed under argon and a degassed solution of 3-azidopropyl 2-bromo-2-methylpropanoate 
(1 equiv) dissolved in anisole was injected. The reaction mixture was heated to 90 °C and 
allowed to react for 1-2 h before turning viscous. The resulting gel was diluted with THF, 
purified from copper via an alumina plug and transferred to a 1.0 k MWCO Spectrum Labs 
dialysis bag and dialyzed against methanol. The purified solution was concentrated under 
vacuum to yield a white powder. From GPC: Mn =  5,500 gmol-1, degree of polymerization ~ 20, 
Đ ~ 1.06. 1H NMR (400 MHz, CDCl3): δ 7.18-6.14 (b, 80H), 4.60-4.07 (b, 40H), 3.08-2.49 (b, 
60H), 2.04-0.99 (b, 260H). (Figure S7) 
 
Synthesis of NB-PBoc, 4 
Copper (I) bromide (0.5 equiv), 3 (1 equiv), and norbornene propargyl imide (7.5 equiv) and 
were added to a dry three-neck round bottom flask equipped with a stir bar and reflux condenser. 
The setup was subjected to three vacuum-argon cycles. Degassed N,N,N’,N”,N”-


















































transferred to the 3-neck flask under Argon. The reaction mixture was heated to 50 °C and stirred 
for 24 h. The resulting gel was diluted with THF, purified from copper via an alumina plug and 
transferred to a 1.0 k MWCO Spectrum Labs dialysis bag and dialyzed against methanol. The 
purified solution was concentrated under vacuum and dried to yield an off-white powder. 1H 
NMR (400 MHz, CDCl3): δ 7.50-7.46 (b s, 0.9H), 7.15-6.18 (b, 80H), 6.27 (s, 2H), 4.72 (broad s, 
1.8zH), 4.55-4.02 (b, 40H), 3.25 (broad s, 1.8H), 3.00-2.39 (b, 60H), 2.17 (s, 2H), 2.01-1.15 (b, 
270H). (Figure S8) 
 
Synthesis of PBoc Brush, 5 
Polymer 4 (50 equiv) was dissolved in dry DMF to a concentration of 0.1 M and degassed with 
Argon in a reaction vial equipped with a stir bar. A degassed solution of Grubbs’ third-
generation catalyst (1 equiv) in dry DMF was added to the vial and then stirred at 35 °C for 12-
18 h. The crude solution was then transferred to a 10 k MWCO Spectrum Labs dialysis bag and 
dialyzed against methanol, with 10 solvent exchanges. The purified solution was concentrated 
under vacuum to yield an off-white powder. From GPC: Mn = 45,000 gmol-1 and 5,800 gmol-1, 
degree of polymerization ~ 8, Đ ~ 1.10. 1H NMR (400 MHz, CDCl3): δ 7.50-7.46 (b s, 0.9H), 
7.15-6.18 (b, 80H), 6.27 (s, 2H), 5.75 (d, 0.5H), 5.23 (d, 0.5H), 4.72 (broad s, 1.8zH), 4.55-4.02 
(b, 40H), 3.25 (broad s, 1.8H), 3.00-2.39 (b, 60H), 2.17 (s, 2H), 2.01-1.15 (b, 260H). (Figure S9 
and S10) 
 
Synthesis of PMAS Brush, 6 
5 (1 equiv boc monomer) was dissolved in a 1:1 mixture of trifluoroacetic acid (1.5 equiv) and 
dry CH2Cl2 and stirred at room temperature for 2 h. The reaction mixture was then concentrated 
under vacuum and neutralized by slowly adding triethylamine (TEA; 3 equiv) and then stirring 
for 10 min. This solution was dissolved in CH2Cl2 and washed 1 x deionized water and 1 x brine 
before being dried over magnesium sulfate and concentrated under vacuum to yield a pale brown 
powder. The NMR has residual TEA. 1H NMR (400 MHz, CDCl3): δ 7.50-7.46 (b s, 0.9H), 7.15-
6.18 (b, 80H), 6.27 (s, 2H), 5.62 (broad s, 0.5H), 4.72 (broad s, 1.8zH), 3.92-3.34 (b, 40H), 2.55-
2.30 (b, 60H), 2.17 (s, 2H), 1.60-1.16 (b, 55H). (Figure S11) 
 
Synthesis of PMAS(Pep) Brush, 7 
This procedure was performed open to the atmosphere. 6 (1 equiv amine monomer) was 
dissolved in CHCl3 in a scintillation vial charged with a stir bar. To the vial was added N,N-
diisopropylethylamine (DIPEA) (3 equiv) followed by a solution of bis-1,2-(piperidino)-3-
chlorocyclopropenium chloride (1.5 equiv) in chloroform. The reaction mixture was stirred at 65 
°C for 18 h. The resulting solution was concentrated under vacuum, diluted with methanol, and 
transferred to a 3.5k MWCO Spectrum Labs dialysis bag and dialyzed against methanol. The 
dialyzed solution was finally concentrated under vacuum to yield a brown powder. The NMR 
has residual MeOH. 1H NMR (400 MHz, CDCl3): δ 7.22-6.04 (b, 80H), 4.90-4.39 (b, 40H), 
3.29-2.96 (b, 60H), 1.96-1.00 (b, 450H). (Figure S12) 
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Synthesis of PBoc 4-arm Star, 8 
Copper (I) bromide (0.2 equiv) was added to a dry Schlenk flask equipped with a stir bar and 
deoxygenated via three vacuum-argon cycles. Degassed tert-butyl methyl(4-
vinylbenzyl)carbamate (100 equiv) and degassed N,N,N’,N”,N”-pentamethyldiethylenetriamine 
(PMDETA; 0.2 equiv)  were then added and allowed to stir for ten minutes to form copper 
complex. The mixture was then subjected to three freeze-pump-thaw cycles. The Schlenk flask 
was closed under argon and a degassed solution of pentaerythritol tetrakis(2-bromoisobutyrate) 
(1 equiv) dissolved in anisole was injected. The reaction mixture was heated to 90 °C and 
allowed to react for 12 h before turning viscous. The resulting gel was diluted with CH2Cl2, 
purified from copper via an alumina plug and transferred to a 1.0 k MWCO Spectrum Labs 
dialysis bag and dialyzed against methanol. The purified solution was concentrated under 







































































Đ ~ 1.05. 1H NMR (400 MHz, CDCl3): δ 7.20-6.12 (b, 80H), 4.55-4.05 (b, 40H), 3.01-2.47 (b, 
60H), 2.31-1.10 (b, 265H). (Figure S13) 
 
Synthesis of PMAS 4-arm Star, 9 
8 (1 equiv boc monomer) was dissolved in a 1:1 mixture of trifluoroacetic acid (1.5 equiv) and 
dry CH2Cl2 and stirred at room temperature for 2 h. The reaction mixture was then concentrated 
under vacuum and neutralized by slowly adding triethylamine (TEA; 3 equiv) and then stirring 
for 10 min. This solution was dissolved in CH2Cl2 and washed 1 x deionized water and 1 x brine 
before being dried over magnesium sulfate and concentrated under vacuum to yield a pale brown 
powder. The NMR has residual TEA and MeOH. 1H NMR (400 MHz, CDCl3): δ 7.23-6.23 (b, 
80H), 3.80-3.50 (b, 40H), 2.50-2.22 (b, 60H), 1.59-1.12 (b, 58H). (Figure S14) 
 
Synthesis of PMAS(Pep) 4-arm Star, 10 
This procedure was performed open to the atmosphere. 9 (1 equiv amine monomer) was 
dissolved in CHCl3 in a scintillation vial charged with a stir bar. To the vial was added N,N-
diisopropylethylamine (DIPEA) (3 equiv) followed by a solution of bis-1,2-(piperidino)-3-
chlorocyclopropenium chloride (1.5 equiv) in chloroform. The reaction mixture was stirred at 65 
°C for 6 h. The resulting solution was concentrated under vacuum, diluted with methanol, and 
transferred to a 3.5k MWCO Spectrum Labs dialysis bag and dialyzed against methanol. The 
dialyzed solution was finally concentrated under vacuum to yield a brown powder. The NMR 
has residual MeOH and H2O. 1H NMR (400 MHz, CDCl3): δ 7.29-6.29 (b, 80H), 4.83-4.44 (b, 
40H), 3.26-2.95 (b, 65H), 1.45-0.85 (b, 600H). (Figure S15) 
 
Supplementary Tables and Figures 
 




[a] (kDa) Charge ratio[b] DH (nm) ζ potential (mV) 
PEI 25 50:1 490 ± 60 40 ± 10 
PEI(Pep) 166 8:1 425 ± 100 65 ± 5 
PEI(Mo) 164 20:1 400 ± 110 60 ± 6 
PMAS(Pep) 53 5.5:1 140 ± 60 27 ± 8 
PMAS(Mo) 53 5.5:1 215 ± 25 43 ± 6 
a Molecular mass of transfection agent, calculated based on commercial 25 k linear PEI; for 
PMAS(R) materials, PMAS was measured by GPC calibrated using polystyrene standards of 
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narrow dispersity, then calculated for the corresponding TAC group. b Ratio of either N to 
phosphate anions (PEI) or TAC to phosphate anions (all others).  
 
Table S2. Characterization of butyl- and isopropyl-derived transfection agents and polyplexes at 
optimal transfection efficacy. 
Transfection 
agent MM
[a] (kDa) Charge ratio[b] DH (nm) ζ potential (mV) 
PEI(Bu) 215 6:1 110 ± 40 45 ± 7 
PEI(iP) 180 35:1 100 ± 40 58 ± 5 
PMAS(Bu) 25 12:1 150 ± 50 31 ± 8 
PMAS(iP) 21 5:1 160 ± 40 44 ± 6 
a Molecular mass of transfection agent, calculated based on commercial 25 k linear PEI; for 
PMAS(R) materials, PMAS was measured by GPC calibrated using polystyrene standards of 
narrow dispersity, then calculated for the corresponding TAC group. b Ratio of TAC to 
phosphate anions. 
 
Table S3. Polymer loading and pDNA weight ratios for gel electrophoresis and transfection 
experiments 
Transfection [µg][a] 2.5 5 10 20 50 100 
Gel [ng][b] 42 83 167 333 835 1665 
Weight Ratio[c] 0.83:1 1.66:1 3.33:1 6.66:1 16.7:1 33.3:1 
a Mass of polymer added for biocompatibility and transfection experiments. b Mass of polymer 









Figure S2. Luciferase expression in HEK-293T cells transfected with pDNA containing the 
firefly luciferase reporter gene using TAC polymers and 25 k linear PEI. Luciferase expression is 
measured after 48 h incubation with specified polymer loadings (all with pDNA loadings of 3 µg 




Figure S3. Gel electrophoresis shift assay of pDNA polyplexes formed with PMAS(Bu) at the 
indicated polymer:pDNA weight ratios. All pDNA is bound in polyplexes at a weight ratio of 
1.66 PMAS(Bu): 1 pDNA.  
 
Figure S4. Gel electrophoresis shift assay of pDNA polyplexes formed with PEI(Bu) at the 
indicated polymer:pDNA weight ratios. All pDNA is bound in polyplexes at a weight ratio of 






Figure S5. Gel electrophoresis shift assay of pDNA polyplexes formed with PMAS(iP) at the 
indicated polymer:pDNA weight ratios. All pDNA is bound in polyplexes at a weight ratio of 
1.66 PMAS(iP): 1 pDNA.  
 
Figure S6. Gel electrophoresis shift assay of pDNA polyplexes formed with PEI(iP) at the 
indicated polymer:pDNA weight ratios. All pDNA is bound in polyplexes at a weight ratio of 




Figure S7. 1H NMR spectrum of N3-PBoc 3 
	 41	
Figure S8. 1H NMR spectrum of NB-PBoc 4 
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Figure S9. 1H NMR spectrum of PBoc Brush 5 
 
 
Figure S10. GPC trace of dialyzed PBoc Brush 5 showing both brush (18 min) and unreacted 
macromonomer (23 min) absorbances. 
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Figure S11. 1H NMR spectrum of PMAS Brush 6 
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Figure S12. 1H NMR spectrum of PMAS(Pep) Brush 7 
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Figure S13. 1H NMR spectrum of PBoc 4-arm Star 8 
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Figure S14. 1H NMR spectrum of PMAS 4-arm Star 9 
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BRINGING CYCLOPROPENIUM TO LIGHT  
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CYCLOPROPENIUM NANOPARTICLES FOR LIVE-CELL IMAGING 
[This section is based on the publication Chem. Commun. 2017, 53, 6187] 
Nanomaterials that offer precise localization and can be readily imaged have found great 
utility as contrast agents in biological and medical research.1–3 In this part, a novel nanoparticle-
based imaging strategy is introduced that couples biocompatible cyclopropenium nanoparticles 
and stimulated Raman scattering (SRS) microscopy. We thus transition from cyclopropenium as 
the functional moiety binding nucleic acids in a polymer, to cyclopropenium serving as the 
framework of a nanoparticle-based image contrast agent.  
Recently, metal nanoparticles, quantum dots (Q-dots), and carbon-based materials have 
become attractive platforms for bioimaging.4,5 Q-dots exhibit narrow light emission and high 
quantum yields that enable multiplexing, and metal nanoparticles offer precise shape tunability. 
However, these systems have been shown to be less than ideal in biological applications due to 
inherent limitations, including cytotoxicity from metal ion leaching, elaborate surface processing 
to maintain stability in fluctuating environments, and small scale syntheses with batch 
variability.6,7 Alternatively, carbon-based materials such as graphene,8 carbon nanotubes,9 and 
nanodiamonds10 have been developed as contrast agents in live-cell imaging, but they require 
precise control of chemical composition for reproducibility.11 
 Different from metal- or carbon-based materials, metal-free polymer nanoparticles have 
great potential in bioimaging and theranostics because of their modular chemical functionality.12,13 
Unfortunately, most polymeric nanoparticles rely on fluorescence reporting, and hence are limited 
by the intrinsic photophysics of fluorophores,14 including self-quenching, broad emission, and 
photobleaching of organic dyes. Further compromising widespread use of polymer-based 
materials is the synthesis of complex architectures, such as those described in part one, including 
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bottle-brushes, star-shaped nanoparticles, and hollow nanomaterials.12 Therefore, it is imperative 
to explore beyond conventional imaging agents and techniques. Developing a biocompatible 
platform of all-polymer nanoparticles that can be readily synthesized and optically imaged in live 
cells could significantly impact biotechnological and diagnostic applications.  
 Stimulated Raman scattering (SRS) is an emerging non-linear vibrational imaging 
technique that can overcome many limitations of fluorescence imaging and other metal-based 
nanoparticle imaging techniques.15–18 Compared to conventional spontaneous Raman imaging, 
SRS provides 108 enhancement in excitation efficiency and over 1000-fold improvement in 
imaging speed through stimulated emission of vibrational transitions by an additional Stokes laser 
beam.19,20 SRS is intrinsically free from photobleaching and blinking, and does not rely on metallic 
nanostructures for localized plasmonic enhancement such as in surface enhanced Raman 
scattering. In addition, the use of picosecond near-infrared lasers permits narrow-band detection 
of sharp vibrational peaks and deep tissue penetration with reduced phototoxicity. Vibrational 
labelling has recently been coupled with SRS microscopy as a powerful technique for 
bioorthogonal chemical imaging of small bio-molecules in live cells and tissues.21–24 Thus far, SRS 
has been limited to small molecule probes, which must be custom-designed to be water-soluble, 
non-cytotoxic, and detectable under high dilution for live-cell imaging. 
 Functional synthetic latex nanoparticles represent a modular platform to generalize SRS 
imaging probes. Miniemulsion polymerization is a facile synthetic method that has been shown to 
reproducibly yield large-scale quantities of polymer nanoparticles with narrow size distribution.25 
Here, we show how the chemistry of the prototypical nanoparticle can be exploited to develop a 
new family of latexes for multiplexed live-cell imaging by SRS (Figure 1). Formation of the latex 
is enabled by a functional surfactant that is covalently incorporated through the hydrophobic 
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styrene moiety, while displaying the hydrophilic head group on the surface of the spherical 
nanoparticle.26 The hydrophilic group is composed of the soft, highly delocalized 
trisaminocyclopropenium (TAC) cation that affords a positive surface charge and resistance to 
flocculation across a wide range of pH values.27 Importantly, the hydrophobic polymer core is 
readily obtained through the radical polymerization of styrene and its derivatives. Introducing 
characteristic chemical bonds as vibrational tags onto the styrene monomer allows high labelling 
efficiency and enables SRS imaging with high sensitivity and specificity. We refer to this new 
family of polymer latexes as Raman-active polymer dots. 
 A key attractive feature of the Raman-active polymer dots is their facile synthesis. The 
parent oil-in-water emulsion is obtained by adding a 95:5 w:w ratio of styrene monomer to TAC 
surfactant in water. A stable latex is obtained by radical polymerization using V-50, a thermally 
activated water-soluble initiator, and heating to 70 °C, followed by a 24 hour dialysis to remove 
unreacted monomer. The use of styrene provides a rich palette to decorate the aromatic unit with 
various vibrational tags for Raman imaging, without disturbing the size distribution of the latex. 
Using styrene derivatives with tiny vibrational labels to dope the emulsion furnished a library of 
Raman-active polymer dots (Figure 2). The uniform dot size can be varied from 30-100 nm by 
Figure 1. Schematic formulation of the latex: miniemulsion polymerization of Raman-
active polymer dots. 
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changing the ratio of monomer to surfactant (SI Table 1 and SI Figures 1-3), with nearly 105 
vibrational labels incorporated in each polymer dot. 
  
Alkyne, nitrile, and carbon-deuterium bonds (C-D) were chosen as bioorthogonal 
vibrational tags since they all exhibit characteristic and mutually resolvable peaks with narrow 
bandwidth (<2 nm) in the Raman region where cells possess minimal endogenous vibrations 
(referred to as the cell Raman-silent region, 1740-2800 cm-1, Figure 2 and SI Figure 4).28  Both 
the alkyne and nitrile bonds were conjugated with the phenyl ring of styrene for enhanced Raman 
cross sections.28 A trimethylsilane-protecting group was employed to further improve the alkyne 































Figure 2. Spontaneous Raman spectra and structure of three distinct Raman-active polymer dots. (a) 
Spontaneous Raman spectra of nanoparticles with orthogonal vibrational modes of alkyne, nitrile, and 
carbon-deuterium bonds in the cell Raman-silent region (from 1740 to 2800 cm-1). The intensity is scaled 
based on the peaks in the Raman-silent region. (b) Schematic structure of three Raman-active polymer 
dots with the core comprising styrene and styrenic derivatives and the surface coated with 
trisaminocyclopropenium (TAC) groups. 
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the nitrile (2232 cm-1, CN-dot).29 Additionally, use of d5-styrene fully separates the frequency 
(2293 cm-1, CD-dot) from the nitrile vibration, compared to d8-styrene that exhibits a broad 
spectrum due to the backbone C-D vibrations.30  
 We next studied the cellular behavior of Raman-active polymer dots as contrast agents in 
live-cell imaging. The latexes were synthesized without the use of any organic solvents or extra 
surface modification enabling their rapid application into cells. Live HeLa cells were separately 
incubated with CC-dots, CN-dots, or CD-dots, and we found that all Raman-active polymer dots 
efficiently entered the cells within 2 hours and accumulated mainly in vesicular structures near the 
cell nucleus (Figure 3). Imaging at the characteristic frequencies of alkyne (2163 cm-1), nitrile 
(2232 cm-1), and C-D (2293 cm-1), cells incubated with the corresponding Raman-active 
nanoparticles show exclusive SRS signal with high signal to noise ratio (S/N >5, at 30 µs time 
constant) in the specific on-resonance channel (the colors in all images are pseudo-colors we 
assigned to each frequency). Thus, the three Raman-active polymer nanoparticles were found to 
be spectrally orthogonal in live cells with negligible cross-talk, allowing high fidelity multiplexed 
imaging without the need of spectral unmixing. 
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To determine the intracellular locations of polymer nanoparticles, the endosomes were co-
stained in live HeLa cells with transferrin Texas Red conjugate. The correlative SRS and 
fluorescence imaging revealed high spatial co-localization between the Raman-active nanoparticle 
puncta in the SRS channel and the endosome marker in the fluorescence channel, suggesting the 
cellular entry of nanoparticles through endocytosis (Figure 3d).31  Incubating HeLa cells with 
nanoparticles at 4 °C fully suppressed their cellular entry, further supporting the endocytic 
mechanism of entry (SI Figure 5).31 
Figure 3. SRS imaging of Raman-active polymer dots entry in live HeLa cells. HeLa cells are incubated 
with the (a) CC-dot (b) CN-dot, and (c) CD-dot. Each Raman-active polymer dot shows its distinct 
frequency without cross-talk in cells. The images at 2845 cm-1 are lipid CH2 channels showing cell 
morphology. (d) CC-dots highly co-localize with endosome marker in live HeLa cells, suggesting 
endocytic entry. 
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 Time-dependent cellular entry kinetics were also characterized for all three Raman-active 
polymer dots. In as short as 1 hour, observable quantities of nanoparticles were found inside the 
cells, indicating fast entry kinetics,2 likely due to the positive charge of cyclopropenium on the 
nanoparticle surface. This is in agreement with other studies showing positively-charged surfaces 
and nanoparticle sizes of ~50 nm to be ideal for rapid cellular uptake.2 After 4 hours of incubation, 
significant amounts of nanoparticles are enriched in the endosomes surrounding the cell nucleus 
(SI Figure 6). Thus, the three Raman-active polymer dots were found to behave similarly with 
rapid entry via endocytosis within an hour, highlighting the fact that doping the styrene latexes 
with different vibrational labels does not introduce variability in their interaction with live cells.  
 Unlike fluorescent polymer nanoparticles that require electronic excitation, Raman 
scattering is based on chemical bond vibration, which is intrinsically free from photobleaching, 
blinking, and self-quenching. Thus, Raman-active polymer nanoparticles were expected to exhibit 
excellent photo-stability for long-term imaging. Indeed, by continuously imaging the nanoparticles 
in live HeLa cells for 100 frames (2.7 seconds per frame), we found minimal reduction in intensity 
(Figure 4a) and that the strong signal is stable, without bleaching or blinking, after nearly 300 
seconds of continuous laser illumination, as shown quantitatively by the steady intensity time 
traces at three dense areas of puncta (Figure 4b,c). Compared to other imaging contrast agents 
which typically show fluorescence intermittency or rapid decay, Raman-active polymer dots 
display high photo-stability under SRS microscopy and are exceptionally well suited for tracking 
applications in live cells for long periods of time.  
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 To demonstrate the broad applicability of Raman-active polymer dots in live-cell imaging, 
we tested their cellular entry capacity and biocompatibility in five cell lines. In addition to HeLa, 
two other cancerous cell lines were evaluated (human breast cancer cells MCF-7 and human 
fibrosarcoma cells HT1080), as well as two non-cancerous cell lines (monkey kidney fibroblast-
like cells COS-7 and mouse embryonic fibroblasts MEF). Incubated with the alkyne-labelled 
polymer dots, all four additional cell lines were efficiently labelled within 2 hours with strong 
accumulation of the Raman-active dots inside the cells (SI Figure 7). Furthermore, cytotoxicity 
assays showed all five cell lines (COS-7, MEF, MCF-7, HT1080, and HeLa) have greater than 
85% (some even more than 95%) viability with all three Raman-active dots after 48 hour culture 
Figure 4. High photo-stability of Raman-active polymer dots in live cells. (a) SRS imaging of CC-dots in 
HeLa cells. Representative frames (1, 20, 50, and 100) are shown to display little change in intensity. 
(b,c) Intensity quantification of SRS images of Raman-active polymer dots in HeLa cells. Steady intensity 
traces of both the whole frame and 3 selected regions (white boxes) demonstrate high photo-stability of 
Raman-active polymer dots after 100 continuous frames. 
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(SI Figure 8). The biocompatible chemical composition of our organic nanoparticles should be 
responsible for such negligible cytotoxicity. By contrast, Q-dots without surface coating display 
acute toxicity at similar loadings.32 These data demonstrate that Raman-active polymer dots exhibit 
minimal toxicity in all cell lines tested and would be widely applicable as imaging agents across a 
broad range of cells. 
 The ability to quickly identify cell type in a multicomponent system will allow fast readout 
of information in many applications such as cell screening or monitoring long-term spatial 
migration. As the three-color Raman-active polymer dots exhibit high detection orthogonality and 
biocompatibility across multiple cell lines, we employed them for multiplexed live-cell sorting in 
co-culture by SRS microscopy. Each cell type was “color-coded” by incubation with one specific 
Raman-active polymer dot (alkyne for COS-7, nitrile for MEF, and C-D for HeLa cells) after 
which the three cell types were mixed and cultured together.  
 After co-culture of 4 and 24 hours, cells could be unambiguously identified by their 
polymer dot labelling (Figure 5). In both cases, cells were indistinguishable by simple morphology 
inspection or by label-free SRS imaging of the lipid CH2 vibration (2845 cm-1). However, by 
imaging through the unique frequencies of alkyne, nitrile, and C-D, every cell in the frame can be 
rapidly and singularly identified by the color-coding of the Raman-active polymer dots. By 
merging all three channels together with the lipid CH2 image, not only the identity of the cell type, 
but also the spatial location of each cell in a co-culture can be clearly mapped out. This 
demonstrates multi-color Raman-active polymer dots as promising live-cell multiplexed imaging 
agents.  
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 We thus have developed a new strategy to image organic polymeric nanoparticles via 
stimulated Raman scattering that is free from the use of fluorescent dyes or metals. Characteristic 
chemical bonds of minimal size and orthogonal vibrational modes with narrow bandwidth were 
rationally designed and incorporated into organic polymer nanoparticles in a robust one-step 
synthesis. The nanoparticles were shown to have rapid cellular entry kinetics and high 
biocompatibility across a broad range of cell lines. We achieved near-infrared multi-color SRS 
imaging of these materials in live cells demonstrating high sensitivity, specificity, and photo-
stability. We further applied this technology in multiplexed live-cell sorting with unambiguous 
identification of cell types in co-culture with fast readout. The multiplexing capability can be 
further expanded by precisely tuning the vibrational frequencies of the alkyne and nitrile through 
isotope editing,33  and efforts to target these nanoparticles towards specific cell types are discussed 
in the next section. Addressing the previous issues of cytotoxicity, photo-stability, and synthetic 
Figure 5. Multiplexed live-cell sorting in co-culture of three cell lines. Each cell line is color-coded with 
specific Raman-active polymer dots (CC-dot for COS-7, CN-dot for MEF, and CD-dot for HeLa) before 
being mixed in the co-culture. Cell types are unambiguously identified by 3-color polymer dots with 
multiplexed SRS imaging after 4 hours (a) and 24 hours (b).  
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robustness for nanoparticle-based imaging reagents, we anticipate that multiplexed Raman-active 
polymer dots coupled with SRS microscopy will be an important technology in nanoparticle-based 
live-cell imaging for biotechnology and theranostic applications.  
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DESIGN OF TARGETABLE NANOPARTICLES FOR PRECISION TREATMENT 
Advances in nanomedicine and diagnostics rely on the specific targeting of nanoparticles 
to cells and tissues of interest. Nanomaterials that can carry both therapeutic and imaging agents 
for diagnostic and treatment applications are of the highest interest for theranostic purposes. As 
most organic nanoparticles do not have sufficient contrast for long-term imaging they have 
predominantly been relegated to strictly therapeutic delivery agents.34,35 However, our Raman-
active polymer dots overcome this limitation as they possess an intrinsic contrast mechanism based 
on specific molecular vibrations positioning them as a promising theranostic platform. 
Whereas in the previous section our Raman-active polymer dots were artificially targeted 
through incubation with a specific cell line before mixing, we sought a platform where our 
materials could be endowed with precise targeting moieties. Currently available theranostic 
technologies are mostly reliant on passive targeting of disease sites, such as the enhanced 
permeability and retention effect, where nanoparticles slowly accumulate over time in the leaky 
vasculature of tumor tissue. This mode of targeting is limited to cancerous and inflammatory tissue 
and the key parameter is circulation time. As such, nanoparticles are engineered to have stealth 
surface modifications and appropriate size to prevent non-specific binding and excretion.36,37 
Instead, we desired a modular platform for active targeting, where disease- and cell-specific 
targeting ligands could be functionalized onto the nanoparticle surface. The dominant targeting 
ligands are antibodies and other proteins that have high specificity for antigens or cell-membrane 
based receptors. Molecular-level recognition of diseased tissues has the potential to reduce non-
specific off-target effects by promoting precise accumulation at the diseased site.34,35,38,39 Thus, 
active targeting where we could functionalize specific proteins onto the surface of nanoparticles 
was our next goal in the development of Raman-active polymer dots. 
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We first endeavored to modulate our prototypical nanoparticle synthesis. Just as styrene 
provided a platform to decorate the aromatic unit with various vibrational tags for Raman imaging, 
we hoped to exploit the chemistry of the cyclopropenium cation to install functional handles. As 
cyclopropenium formed the hydrophilic component of our surfactant, tuning the amino 
substituents would lead to surface-level modifications on the nanoparticle. We specifically studied 
functional groups that could be employed downstream in robust click chemistry to targeting 
ligands, namely, azido, propargyl, and allyl moieties (Figure 6). Azides or alkynes could be 
specifically linked with the corresponding functional group on a targeting ligand via CuAAC click 
chemistry. Similarly, allyl groups could be employed in precise thiol-ene coupling with reactive 
cysteine residues in a protein.40,41  
Unfortunately, none of these proposed structures yielded stable nanoparticles. Neither the 
azido nor propargyl amines were able to be transformed into a corresponding BACCl derivative 
necessary for functionalization onto the methylaminostyrene polymerizable group (Figure 7a,b). 
We suspect this was due to off-target effects during the harsh hydrolysis conditions necessary to 
form the cyclopropenone. Thus, for these derivatives we were unable to synthesize a polymerizable 
monomer. In the case of the allyl derivative, the functionalization onto cyclopropenium and 
methylaminostyrene was smooth, but we were never able to isolate stable well-defined 
Figure 6. Attempted molecular structures for targeted nanoparticles include incorporation of azide, 
alkyne, or alkene functional groups. 
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nanoparticles (Figure 7c). This can most likely be attributed to the high degree of crosslinking 
available in these monomers, with five vinyl groups present per monomer. These unsuccessful 
synthetic efforts thus established a limit to the modularity of cyclopropenium chemistry and 
suggested that a different approach was necessary for the design of targetable Raman-active 
polymer dots.  
We were ultimately able to synthesize targetable nanoparticles through a reengineering of 
the nanoparticle design. Rather than employing our polymerizable monomer as the surfactant, we 
designed an amphiphilic block copolymer comprising styrene and cyclopropenium-based blocks. 
Utilizing a block copolymer framework permitted chain-end functionalization with a functional 
handle of interest. We selected an NHS ester moiety due to its specific reactivity with primary 
amines, commonly found either on the N-terminus of proteins or in lysine residues, to afford stable 
amide bonds.40 Rationally designing the block copolymer such that the NHS ester was on the 
hydrophilic (i.e. cyclopropenium) end, ensured it would be present on the nanoparticle surface 
(Figure 8). Treating this end-functionalized block copolymer as a surfactant for miniemulsion 
polymerizations permits the incorporation of fluorescent dyes or tiny vibrational labels as co-
Figure 7. Unsuccessful synthetic efforts in the design of functional cyclopropenium derivatives. Azido 
(a) and propargyl (b) amines could not be transformed into the necessary cyclopropenone nor 
bisaminocyclopropenium chloride derivatives. Polymerization of allyl amines (c) did not yield stable 
nanoparticles. 
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monomers. Subsequent functionalization with a protein of interest affords a surface-decorated 
nanoparticle comprising cyclopropenium with imaging modalities in the hydrophobic core. 
We prepared this NHS ester-terminated block copolymer as a variant of our established 
post-polymerization functionalization chemistry described in the introduction (Figure 9 and SI 
Figures 9-12). Starting with a heterofunctional NHS ester ATRP initiator, we polymerized an N-
Boc protected methylaminostyrene monomer, which yields polymers with controllable molecular 
mass and narrow dispersity. This homopolymer was then employed as a macroinitiator for the 
polymerization of styrene. Though the Boc-protected monomer is deactivating, slowing the rate of 
styrene polymerization, the order of these reactions is essential. The NHS ester ends up on the 
Boc-terminus, which we derivatize to form the hydrophilic cyclopropenium. This functionalization 
is accomplished in two steps: the Boc group is deprotected to yield the free secondary amine and 
Figure 8. Chemical structure and graphical representation of 
NHS ester terminated block copolymer employed as surfactant 
for targetable nanoparticles. 
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then this amine is quantitatively converted to a cyclopropenium ring through addition of a BACCl 
salt. We chose to use the piperidine derivative (BAC(Pep)) due to its high biocompatibility as 
demonstrated in part one. This functionalized block copolymer, denoted NHS-PMAS(Pep)-PS, 
was then employed in the standard nanoparticle reaction to afford nanoparticles with a styrenic 
core and cyclopropenium-based corona with pendent NHS ester moieties. Modulating the 
emulsion polymerization to incorporate either fluorescent dyes or vibrational labels afforded NHS-
ester coated nanoparticles that could be imaged by either fluorescence or SRS microscopy (SI 
Table 2). 
  
 Interested in exploiting the unique chemistry of these nanoparticles for theranostic 
applications, we initiated a collaboration with Prof. Valerio Dorrello, an expert in bioengineering. 
As of this writing this collaboration is ongoing with only preliminary results as we seek internal 
Figure 9. Synthetic scheme for targetable nanoparticles. (i) CuBr, TPMA, Anisole, 90 °C, 4 h; (ii) CuBr, 
PMDETA, Anisole, 100 °C, 24 h; (iii) 1. TMSCl, MeOH/CH2Cl2, 0 °C 2. NaOH; (iv) CHCl3, DIPEA, 65 
°C, 3 h; (v) Styrene, V-50, H2O, 70 °C, 16-24 h. 
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or federal funding.  Our ultimate goal is to employ targetable Raman-active polymer dots as a 
platform to specifically target and remove diseased lung tissue. 
 Hundreds of millions of people suffer from chronic respiratory diseases worldwide, and in 
the United States, end-stage lung disease is the third leading cause of death.42 Lung transplantation, 
which is the only definitive treatment, remains limited by a severe shortage of donor organs.43 Due 
to the extreme complexity of the lung with its 3D architecture, diversity in cell composition, and 
highly specialized matrix, prior attempts to bioengineer a functional lung have been largely 
unsuccessful.44,45 We imagine that early intervention via targeted cell therapy could promote lung 
repair and regeneration, slow disease progression, and ultimately avoid the need for transplant. 
 A challenging paradigm shift in both lung disease and regenerative medicine will be to 
remove only defective cells, while preserving healthy cells and the surrounding lung vasculature 
and architecture. In particular, the dysfunction or injury of alveolar type II (ATII) epithelial cells, 
which are responsible for the production and recycling of pulmonary surfactant, has been 
implicated in multiple acute and chronic lung diseases.46–48 Compared to previous attempts 
involving full decellularization of the lung, targeting damaged ATII cells exclusively has posed 
unsurmountable hurdles.44,45,47  Developing innovative precisely targeted therapies of ATII cells 
is thus of high import.  
 Our theranostic approach involves decorating Raman-active polymer dots with two distinct 
proteins for both precision targeting and treatment. Lung surfactant protein A is specifically 
produced and recycled by ATII cells,49 thus we envision it can serve as a targeting ligand for these 
cells. For treatment, we chose Pseudomonas aeruginosa exotoxin as a well-established toxin that 
can exert cytotoxic effects in cells.50 Binding SP-A to PE through Raman-active polymer dots will 
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furnish a targeted, toxic, trackable molecule. This theranostic targeting ligand-nanoparticle-toxin 
(TNT) can specifically trigger apoptosis of ATII cells, leaving a void that could then be 
repopulated by healthy lung progenitors affording long-lasting repair and regeneration (Figure 
10). This strategy thus provides sustained recovery while current treatments are only supportive.  
At this point, we have established the foundation for this work, demonstrating the 
conjugation of a model fluorescent bovine serum albumin (BSA) protein to our targetable Raman-
active polymer dots. The nanoparticles and fluorescent BSA were covalently linked via rapid 
reaction of the NHS ester moiety with primary amines on the protein, and then purified by 
ultracentrifugation. As we could calculate the number of nanoparticles in solution by, 
!" = 6%&'() 
where m is the mass of particles, ' is the density of the polymer (assumed to be 1.045 for 
styrene), and d is the diameter of the particles, but were unable to calculate the exact number of 
polymer chains per nanoparticle, we performed the reaction with high excess of protein to ensure 
reaction (ca. 104). The obtained protein-nanoparticle conjugate was characterized by fluorimetry 
and dynamic light scattering demonstrating a stable signal and discrete size (SI Figures 13-14). 
Figure 10. Theranostic approach for the targeting and treatment of end-stage lung disease. Targeting 
ligand-nanoparticle-toxin (TNT) conjugates will specifically target and destroy injured ATII epithelial 
cells . The void left by deceased ATII cells can then be repopulated by healthy exogenous ATII cells to 
re-establish alveolar homeostasis.  
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This control experiment suggests the high potential for targetable Raman-active polymer dots as 
theranostic platforms.  
We thus have begun to expand upon the applications of Raman-active polymer dots as both 
a targetable and therapeutic system. Synthesis of an end-functionalized amphiphilic block 
copolymer enabled the incorporation of an NHS ester group into the nanoparticle synthesis. With 
the block copolymer as a functional surfactant, the emulsion polymerization again could be 
modulated to include either fluorescent dyes or vibrational labels. The resulting NHS-ester coated 
nanoparticles could then be imaged accordingly by either fluorescence or SRS microscopy. We 
also have established that these nanoparticles can be conjugated with proteins, highlighting their 
future potential as a theranostic material for the precise treatment of lung diseases. Furthermore, 
due to the modularity of our approach, we expect that these targetable, trackable nanoparticles 
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All materials were purchased from Sigma-Aldrich and used without further purification, except 
as noted below. Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), 
penicillin/streptomycin, human recombinant insulin, fluorescent FITC bovine serum albumin, 
and transferrin Texas Red conjugate were purchased from Invitrogen. Eagle’s Minimum 
Essential Medium (EMEM) medium was purchased from ATCC. Spectrum Labs dialysis bags 
were purchased from VWR. Eluents for column chromatography were HPLC grade and 
purchased from Fisher Scientific. Deuterated solvents used for NMR spectroscopy were 
purchased from Thermo Fisher Scientific. Organic solutions were concentrated with a Buchi 
rotary evaporator.  Styrene, d5-styrene, and 4-cyanostyrene were passed over a column of neutral 
alumina to remove inhibitor prior to polymerization. 4-(trimethylsilylethynyl)styrene and the 
trisaminocyclopropenium monomer were synthesized according to previously reported 
procedures. [Ref. #26 and #29] 
Cell culture 
HeLa, Cos-7, and MEF cells were grown in DMEM culture medium with 10% v/v FBS and 1% 
v/v penicillin/streptomycin. HT1080 cells were grown in EMEM culture medium with 10% v/v 
FBS and 1% v/v penicillin/streptomycin. MCF-7 cells were grown in EMEM culture medium 
with 10% v/v FBS, 1% v/v penicillin/streptomycin and 0.01 mg/ml human recombinant insulin. 
All cultures were incubated in humidified tissue incubators at 37 °C and 5% CO2. 
Dynamic light scattering 
 
Nanoparticle size and zeta potential were measured on a Malvern Zetasizer Nano ZS (Malvern, 
United Kingdom). For all measurements, nanoparticles were diluted 1:100 in Milli-Q water at 
neutral pH. The reported diameters are the average of three measurements, where each 
measurement comprises at least 10 acquisitions. The zeta potential was calculated according to 
the Smoluchowski approximation.  
SRS microscopy 
A custom-modified integrated laser source (picoEMERALD, Applied Physics & Electronics, 
Inc.), is used to produce a Stokes beam (1064 nm, 6 ps) with intensity modulated sinusoidally at 
8 MHz and a pump beam (tunable from 720 to 990 nm, 5–6 ps) both at 80 MHz repetition rate. 
Two beams are spatially and temporally overlapped before coupled into an inverted multiphoton 
laser-scanning microscope (FV1200MPE, Olympus) with optimized near-IR throughput. Lasers 
are focused onto the cell samples through a 25× water objective (XLPlan N, 1.05 N.A. MP, 
Olympus) and collected with an oil condenser lens (1.4 N.A., Olympus) after the sample. The 
Stokes beam is blocked with a high O.D. bandpass filter (890/220 CARS, Chroma Technology) 
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and only the pump beam is collected with a large area Si photodiode (FDS1010, Thorlabs) 
reverse-biased at a 64 DC voltage. The output photocurrent is electronically filtered (KR 2724, 
KR electronics), terminated with 50 W, and demodulated using a radio frequency lock-in 
amplifier (SR844, Stanford Research Systems) to extract the stimulated Raman loss signal with 
near shot-noise-limited sensitivity. The output signal of the lock-in amplifier at each pixel is sent 
to the analog interface box (FV10-ANALOG, Olympus) of the microscope and images are 
generated using Fluoview software (Olympus). The imaging experiments are all performed with 
40 mW pump beam and 66 mW modulated Stokes beam (measured after the objective) at all 
frequencies. All images except those in the photo-stability test are acquired with 30 µs time 
constant from the lock-in amplifier and 100 µs pixel dwell time with ~27 s per frame (512 × 512 
pixels). In photo-stability test with continuous imaging of 100 frames, 3 µs time constant using a 
fast lock-in amplifier (HF2LI, Zurich instrument) and 8 µs pixel dwell time are used for 
collecting 100 frames with 2.7 s per frame (512 × 512 pixels).  
Spontaneous Raman spectroscopy 
The spontaneous Raman spectra were collected on a confocal Raman microscope (Xplora, 
Horiba Jobin Yvon) at room temperature. A 27 mW (after the objective), 532-nm diode laser was 
used to excite the nanoparticle solutions through a 50 × air objective (MPlan N, 0.75 N.A., 
Olympus). The total data acquisition time for each sample was 10 s using the LabSpec 6 
software. 
Live-cell SRS imaging 
For all SRS imaging experiments, cells are first seeded on glass coverslips in 24-well plates in 
~0.5 mL culture medium for 2 days at 37 °C and 5% CO2 before experiments. 
For multicolor experiments, HeLa cells are incubated with ~1 nM alkyne, nitrile or deuterium 
labelled polymer dots (500-1500× dilution from stock solution) for 2 h before imaging. 
For endosome co-localization experiment, HeLa cells are incubated with ~1 nM alkyne labelled 
polymer nanoparticles and 25 µg/ml transferrin Texas Red conjugate for 1 h before imaging.  
For low-temperature cellular entry experiment, HeLa cells are incubated with ~1 nM alkyne 
labelled polymer dots at 4 °C for 2 h before imaging. 
For time-dependent cellular entry experiments, HeLa cells are separately incubated with ~1 nM 
alkyne, nitrile and deuterium labelled polymer dots for 1, 2 and 4 h before imaging. 
For photo-stability experiment, HeLa cells are incubated with ~1 nM alkyne labelled polymer 
dots for 2 h before continuous imaging of 100 frames. 
For imaging experiments in multiple cells lines, all cells (COS-7, MEF, MCF-7 and HT1080) are 
incubated with ~1 nM alkyne labelled polymer dots for 2 h before imaging. 
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For multiplexed cell-type sorting experiments, COS-7, MEF and HeLa cells are specifically 
incubated with ~1 nM alkyne, nitrile and deuterium labelled polymer dots for 2.5 h. Then cells 
are trypsinized, mixed and seeded on coverslips in co-culture for 4 h and 24 h before imaging. 
After all incubations, cells are washed with PBS solution for three times and the glass coverslips 
are taken out to assemble into imaging chambers filled with PBS for live-cell SRS imaging. 
Cell viability  
All cell lines are incubated with ~1nM alkyne, nitrile, and deuterium labelled polymer dots for 4 
h. This media was then removed and replaced with fresh media and the cells were allowed to 
grow in the presence of internalized nanoparticles for two days. Trypan blue dye exclusion cell 
counting was then performed in triplicate with an automated cell counter (ViCell, Beckman-
Coulter). Cell viability under experimental conditions is the viable cell count reported as a 
percentage relative to untreated cells. 
Imaging processing 
All images are acquired with FluoView scanning software, assigned color and analyzed by 
ImageJ. 
Fluorimetry 
Fluorescence emission spectra were obtained on a Horiba Fluoromax-4.  
NMR Spectroscopy 
1H NMR spectra were recorded on a Bruker Avance III 400 MHz spectrometer. Standard 
abbreviations indicating multiplicity were used as follows: s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet), b (broad). 
Synthesis 
 
Raman-active nanoparticle synthesis and purification 
Nanoparticles were synthesized following a general procedure that was scaled accordingly using 
the indicated weight percentages for each monomer: TAC, styrene, and where applicable, 4-
(trimethylsilylethynyl)styrene, 4-cyanostyrene, and d5-styrene. To the mixture of monomers was 
added 2,2-azobis(2-methylpropionamidine) dihydrochloride (V-50) and deionized water such 
that there was 10 wt% monomers. The mixture was vortexed for 30 s and then added to a two-
neck flask fitted with a condenser and stir bar. The solution was sparged with Ar for 15 min and 
then stirred at 70 °C for 16-24 h. The reaction was then cooled, transferred to a 1k MWCO 
Spectrum Labs dialysis bag and dialyzed against methanol for 24 h to remove unreacted 
monomer. The resulting solution was then diluted 1:1 in water to make the nanoparticle stock 
solution. (Table S1) 
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Synthesis of 1 
Boc-protected diethanolamine (1 equiv), 5-azidopentanoic acid (3 equiv), and 4-
dimethylaminopyridine (DMAP; 1 equiv) were dissolved in DCM and cooled in an ice bath. 
N,N’-dicyclohexylcarbodiimide (DCC; 3 equiv) was dissolved in a 2M solution of DMF and 
added dropwise to the solution. The reaction was left to stir overnight and then the white 
precipitate was filtered off. The solution was diluted with DCM and washed 3 x NaHSO4 (aq), 3 
x NaHCO3 (aq), and 1 x brine, and then dried with Na2SO4 and concentrated. The crude product 
was purified by column chromatography in 20:80 EtOAc:Hexanes to afford the title compound 
as a pale brown oil (85% Yield). 1H NMR (400 MHz, CDCl3): δ 4.20 (t, 4H), 3.41 (t, 4H), 2.35 (t, 
4H), 1.93 (m, 4H), 1.8 (m, 4H), 1.65 (b 4H), 1.45 (s, 9H). MS (ESI): Calculated [M+H]+: 456.25; 
Observed:  456.2570. 
 
Synthesis of 2 
1 (1 equiv) was dissolved in methanol and sparged with Ar for 15 min in an ice bath. 
Tetrabutylammonium fluoride (TBAF; 5 equiv) was then added, and the solution was left to stir 
for 12 h under Ar. The solution was then concentrated under vacuum and redissolved in a 
minimal amount of chloroform and pentachlorocyclopropane (0.15 equiv) was slowly added 
under Ar. After 12 h this solution was concentrated under vacuum to a pale brown oil. 1H NMR 
(400 MHz, CDCl3): δ 4.44 (t, 12H), 3.23 (t, 12H), 2.35 (t, 4H), 1.71-1.56 (b, 24H), 1.41 (t, 12 H)  
MS (ESI): Calculated [M+H]+: 1099.11; Observed: 1099.1250. 
 
Synthesis of tris-1,2,3-(diapropargylamino)-cyclopropenium chloride, 3 
 
Dipropargylamine (7.5 equiv) was slowly added to a solution of pentachlorocyclopropane (1.0 
equiv) in CHCl3 (1M) in a round bottom flask immersed in an ice bath. The solution turned dark 
red and after stirring overnight was concentrated under vacuum to yield a crude red-brown solid. 
This solid was redissolved in CH2Cl2 and then washed 3 x 1M HCl, 1 x deionized water and 1 x 





















































(400 MHz, CDCl3): δ 3.52 (d, 12H), 2.22 (t, 6H). MS (ESI): Calculated [M+H]+: 347.85; 
Observed: 348.82. 
 
Procedures for the synthesis of NHS ester containing block copolymers 
 
Synthesis of NHS-PBoc, 4 
Copper (I) bromide (0.5 equiv) and tris(2-pyridylmethyl)amine (TPMA; 0.5 equiv) were added 
to a dry Schlenk flask equipped with a stir bar and deoxygenated via three vacuum-argon cycles. 
Degassed tert-butyl methyl(4-vinylbenzyl)carbamate (100 equiv) was then added and allowed to 
stir for ten minutes to form copper complex. The mixture was then subjected to three freeze-
pump-thaw cycles. The Schlenk flask was closed under argon and a degassed solution of 2-
bromoisobutanoic acid N-hydroxysuccinmide ester (1 equiv) dissolved in anisole was injected. 
The reaction mixture was heated to 90 °C and allowed to react for 4 h before turning viscous. 
The resulting gel was diluted with THF, purified from copper via an alumina plug and 
transferred to a 3.5 k MWCO Spectrum Labs dialysis bag and dialyzed against methanol. The 
purified solution was concentrated under vacuum to yield a white powder. From GPC: Mn =  
9,500 gmol-1, degree of polymerization ~ 40, Đ ~ 1.10. 1H NMR (400 MHz, CDCl3): δ 7.12-6.18 
(b, 160H), 4.55-4.03 (b, 80H), 2.99-2.40 (b, 120H), 1.75-1.15 (b, 500H). (Figure S9) 
 
Synthesis of NHS-PBoc-PS, 5 
Copper (I) bromide (0.5 equiv) was added to a dry Schlenk equipped with a stir bar and 
deoxygenated via three vacuum-argon cycles. Degassed N,N,N’,N”,N”-















































to stir for 10 minutes. Degassed styrene (100 equiv) was then added to the mixture and subjected 
to three freeze-pump-thaw cycles. The Schlenk flask was closed under argon and a degassed 
solution of 4  (1 equiv) in anisole (0.5 mL) was injected. The mixture was heated to 100 °C and 
allowed to react for 24 h. The resulting solution was diluted with THF, passed over an alumina 
plug, and transferred to a 3.5 k MWCO Spectrum Labs dialysis bag and dialyzed against 
methanol. The purified solution was concentrated under vacuum to yield an off-white powder. 
GPC and 1H NMR indicate polymer contains ~40 units Boc-protected monomer and ~20 units 
styrene, Đ ~ 1.15. 1H NMR (400 MHz, CDCl3): δ 7.21-6.11 (b, 240H), 4.55-3.97 (b, 80H), 3.01-
2.40  (b, 120H), 1.77-1.14 (b, 540H). (Figure S10) 
 
Synthesis of NHS-PMAS-PS, 6 
5 (1 equiv Boc monomer) was dissolved in a 3:1 dichloromethane:methanol solution in a round 
bottom flask under argon. The flask was put on an ice bath and trimethylsilane chloride (TMSCl; 
7 equiv) was added. The reaction was allowed to stir to room temperature with a gas outlet, and 
then concentrated under vacuum to yield an off-white powder. The powder was redissolved in 
methanol and 0.5 M NaOH was added dropwise, with stirring, until the polymer precipitated 
from solution. The suspension was centrifuged and the supernatant decanted. The polymer was 
washed twice more with deionized water and collected by centrifugation. The resulting polymer 
was dried under vacuum. 1H NMR (400 MHz, CD2Cl2): δ 7.28-6.28 (b, 240H), 3.80-3.42 (b, 
80H), 2.53-2.16 (b, 120H), 1.60-1.20 (b, 200H). (Figure S11) 
 
Synthesis of NHS-PMAS(Pep)-PS, 7 
This procedure was performed open to the atmosphere. 6 (1 equiv amine monomer) was 
dissolved in chloroform in a scintillation vial charged with a stir bar. To the vial was added N,N-
diisopropylethylamine (DIPEA; 3 equiv) followed by a solution of bis-1,2-(piperidino)-3-
chlorocyclopropenium chloride (1.5 equiv) in chloroform. The reaction mixture was stirred at 65 
°C for 6 h. The resulting solution was concentrated under vacuum, diluted with methanol, and 
transferred to a 3.5k MWCO Spectrum Labs dialysis bag and dialyzed against methanol. The 
dialyzed solution was finally concentrated under vacuum to yield a brown powder. 1H NMR 
(400 MHz, CDCl3): δ 7.20-6.04 (b, 240H), 4.96-4.27 (b, 80H), 3.68-3.24 (b, 340H), 3.20-2.90 (b, 
120H), 1.90-1.37 (b, 1200 H). (Figure S12) 
 
Targetable nanoparticle synthesis and purification 
Nanoparticles were synthesized following a general procedure using 5 wt% NHS-PMAS(Pep)-
PS (7) and a scaled amount of styrene based on if fluorophores or vibrational labels were 
incorporated. In the absence of an imaging modality 95 wt% styrene was used. For fluorescent 
nanoparticles, 2 wt% fluorescein methacrylate was incorporated with 93 wt% styrene. For 
alkyne-labelled nanoparticles, 47.5 wt% styrene was added with 47.5 wt% 4-
(trimethylsilylethynyl)styrene. Finally, in the case of C-D labelled nanoparticles, 95 wt% d5-
styrene was used. In each case, to the mixture of monomers was added 2,2-azobis(2-
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methylpropionamidine) dihydrochloride (V-50) and deionized water such that there was 10 wt% 
monomers. The mixture was vortexed for 2 min and then added to a two-neck flask fitted with a 
condenser and stir bar. The solution was sparged with Ar for 20 min and then stirred at 70 °C for 
8-24 h. The reaction was then cooled, transferred to a 1k MWCO Spectrum Labs dialysis bag 
and dialyzed against methanol for 24 h to remove unreacted monomer. The resulting solution 
was then diluted 1:1 in water to make the nanoparticle stock solution. (Table S2) 
Conjugation of targetable nanoparticle with fluorescent bovine serum albumin 
Nanoparticles were diluted 100,000X in MilliQ water to give a concentration of 1010 
nanoparticles mL-1. Fluorescent BSA (2 mg, 0.02 µmol) was dissolved and diluted in phosphate 
buffer such that there were 1014 BSA molecules mL-1. An equal volume of the nanoparticle 
solution was added to the BSA solution and then stirred overnight. This reaction was quenched 
with 1 drop of tetraethyleneglycol monoamine to minimize crosslinking. The protein-polymer 
conjugate was purified by 5 rounds of centrifugation at 5000 rpm, each time removing the 
supernatant and then redispersing in fresh MilliQ water.   
 
Supplementary Tables and Figures 
 




TAC wta% Styrene wt% 
Raman-labelled 
styrene wt% DH (nm) ζ potential (mV) 
Alkyne 5 47.5 47.5 55 ± 9 35 ± 5 
Nitrile 5 70 25 60 ± 10 20 ± 10 
Carbon-
Deuterium 
5 - 95 50 ± 7 35 ± 10 





Figure S1. DLS data of alkyne labelled nanoparticles with varying loadings of alkyne monomer 
(a) and trisaminocyclopropenium monomer (b). 
 
Figure S2. DLS data of nitrile labelled nanoparticles with varying loadings of nitrile monomer (a) 
and trisaminocyclopropenium monomer (b). 
 







Figure S4. SRS spectrum of Raman-active polymer dots mixture. Three Raman-active polymer 
dots (CC-dots, CN-dots and CD-dots) show spectrally orthogonal Raman peaks with narrow 




Figure S5. Low-temperature entry inhibition of Raman-active polymer nanoparticles in live 
HeLa cells. HeLa cells are incubated with alkyne labelled polymer nanoparticles for 2 hours at 4 




Figure S6. Time-dependent entry kinetics of Raman-active polymer nanoparticles in live HeLa 
cells. Cells are incubated with alkyne, nitrile and deuterium labelled polymer nanoparticles for 
various time of 1 h (a), 2 h (b) and 4 h (c). Rapid cellular entry is observed in 1 h for all three 





Figure S7. SRS imaging of Raman-active polymer dots in multiple cell lines. COS-7 (a), MEF 
(b), MCF-7 (c) and HT1080 (d) cells are incubated with alkyne labelled polymer dots for 2 hours. 




Figure S8. Viability assay of multiple cell lines incubated with alkyne (green), nitrile (orange), 
and deuterium (cyan) labelled polymer nanoparticles. All cells are incubated with nanoparticles 
for four hours before exchanging with fresh media and allowing the cells to grow for two days. 
All five tested cell lines shows greater than 85% viability after 48 h with the three Raman-active 
polymer nanoparticles. Cell viability is calculated as a percentage relative to control with error 






























Figure S9. 1H NMR spectrum of NHS-PBoc 4 
 84 
 
Figure S10. 1H NMR spectrum of NHS-PBoc-PS 5 
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Figure S11. 1H NMR spectrum of NHS-PMAS-PS 6 
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Table S2. Targetable nanoparticles characterization 
Imaging functionality DH (nm) ζ potential (mV) 
Styrene only 60 ± 11 22 ± 10 
Alkyne 160 ± 70 25 ± 8 
Carbon-Deuterium 92 ± 10 16 ± 5 





Figure S13. Fluorescence emission spectra for alkyne labelled targetable nanoparticles 
conjugated with fluorescent bovine serum albumin (λmax 488). 
 
Figure S14. DLS data of alkyne labelled targetable nanoparticles before and after conjugation 
















BRINGING CYCLOPROPENIUM BACK TO POLYMERS 
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CYCLOPROPENIUM AS A CATIONIC CROSSLINKER 
In this final part, we describe a novel role for cyclopropenium in polymer chemistry. 
Previously, we incorporated cyclopropenium directly – functionalizing at the building block level 
– to explore structure-property relationships as either the backbone or amino substituents were 
modulated. Here, we show how we can exploit the robust reaction of cyclopropenium precursors 
and secondary amines to generate cyclopropenium in situ. Reacting precursors with secondary 
amine-containing polymers generates cyclopropenium as a polymer crosslinker. 
Chemical crosslinking reactions covalently bonding two or more molecules are ubiquitous 
across macromolecules to confer stability and endow functionality.1 Crosslinking of biopolymers 
has been shown to enhance mechanical properties and improve stability, while nanoparticles 
require crosslinkers to maintain their shape and size.2,3 Rationally designing crosslinkers 
represents one of the most promising avenues to install functionality into synthetic polymers.4,5 
Disulfides, which are cleaved to thiols in low pH or reducing environments, can endow a polymer 
with stimuli-responsive biodegradable behavior6,7 and thermally reversible crosslinkers, such as 
those formed from Diels-Alder cycloadditions, can promote self-healing.8–10 Polymers such as 
poly(ethylenimine) (PEI), are widely derivatized via functional crosslinkers to optimize 
performance.11 Especially in biotechnological applications, where stability, biocompatibility, and 
precise targeting will drive clinical acceptance, the design of novel macromolecular crosslinkers 
is highly desirable.2,3 
 Polycationic PEI nanoparticles have been synthesized by crosslinking with diiodoalkanes, 
followed by N-alkylation.12,13 These nanoparticles displayed high stability to a variety of external 
stimuli and possessed a marked antibacterial effect due to the repeating quaternary ammonium 
cation along the polymer backbone. However, in addition to the two-step synthesis these 
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nanoparticles required a multi-step purification.  Here, we present a facile one-step crosslinking of 
secondary amine-containing polymers, such as PEI, to form cyclopropenium-crosslinked cationic 
nanoparticles that does not require purification. 
The cyclopropenium cation possesses unique structural and electronic properties that have 
motivated its incorporation into small molecules for a range of applications including 
organocatalysis14,15 and redox flow batteries16,17. As the smallest Hückel aromatic ring, it possesses 
an unusually high degree of stability for a carbocation18, and when substituted with three amino 
groups, the cation is both stable and isolable.19,20 In fact, the trisaminocyclopropenium cation is 
even stable in strongly alkaline aqueous solutions, motivating its utility as a membrane in alkaline 
fuel cells.21,22 However, in spite of these multifaceted efforts with small molecules, 
cyclopropenium has only recently been incorporated into polymeric structures.23   
We have previously demonstrated that secondary amine-containing polymers can be 
readily functionalized with a bisaminocyclopropenium chloride derivative (BACCl), yielding 
cyclopropenium functionality at the monomer level (Figure 1a).24  While a large variety of BACCl 
salts of different functionalities can be prepared, they are typically highly reactive species and 
Figure 1. Synthesis of cyclopropenium-containing polymers. 
Cyclopropenium can be functionalized at the monomer level with 
reactive bisaminocyclopropenium chloride derivatives (a) or generated as 
a crosslinker in situ by reaction with a stable precursor (b). 
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must be generated immediately before use.  Here we show that by instead employing a stable 
cyclopropenium precursor, namely, pentachlorocyclopropane or tetrachlorocyclopropene, we can 
generate the cation in situ.  
Reaction of a secondary amine-containing polymer, such as PEI, with either 
pentachlorocyclopropane or tetrachlorocyclopropene furnishes cyclopropenium as a crosslink 
between three amino groups (Figure 1b). The reaction takes place rapidly open to air as the 
temperature rises from 0 °C to room temperature, affording a polymer crosslinked by 
trisaminocyclopropenium rings. This crosslinker provides a highly pH-stable cation, and when 
dispersed in aqueous media, these crosslinked polymers form stable nanoparticle aggregates with 
highly positive charge. We believe this strategy will enable the incorporation of the 
cyclopropenium cation into novel classes of advanced materials. 
We chose poly(ethylenimine) (PEI)  as the polymer to crosslink with cyclopropenium as it 
is readily commercially available and the simplest secondary amine-containing polymer. We 
selected two different sizes of  linear PEI (L-PEI; 25 kDa and 10 kDa) to compare the effects of 
crosslinking on different molecular weight. Either pentachlorocyclopropane or 
tetrachlorocyclopropene was added dropwise to a solution of L-PEI in chloroform at different 
ratios corresponding to 30, 10, and 5 mol% crosslinker. As cyclopropenium is capable of 
crosslinking three amines, this corresponds to 90%, 30%, and 15% crosslinking, respectively. In 
all cases, the crosslinked polymer immediately precipitated, indicating reduced solubility and 
successful crosslinking of the parent polymer. Indeed, after the crosslinking reaction the polymers 
were insoluble in all common organic solvents. 
We confirmed the presence of an aromatic cyclopropenium ring in the crosslinked 
polymers with a combination of 13C NMR and FT-IR spectroscopy. While parent L-PEI only 
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shows two 13C signals corresponding to its backbone carbons, the crosslinked polymer has an 
additional signal at 170 ppm indicative of the aromatic carbons of cyclopropenium (Figure 2a). 
Note, that this is significantly farther downfield than the carbons of pentachlorocyclopropane and 
tetrachlorocyclopropene which have carbons at 75 ppm and 125 ppm, respectively.25 As the 
crosslinked polymers were insoluble in all organic solvents, we dispersed them in  CD3OD for 
Figure 2. 13C NMR (a) and FT-IR (b) spectra of parent linear PEI compared to 
those of a crosslinked polymer. The appearance of aromatic carbon peaks (a) and 
disappearance of secondary amine absorbances (b) suggests in situ formation of 
the cyclopropenium cation and crosslinking with secondary amines.  
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these measurements. The presence of cyclopropenium in the crosslinked materials is further 
evidenced by FT-IR spectroscopy which shows attenuation of the secondary amine absorbances at 
~2900 cm-1 (Figure 2b). These data suggest that the insoluble materials comprise aromatic 
cyclopropenium rings.  
We next evaluated the thermal stability of these materials. Crosslinking of 25k L-PEI led 
to increased stability at lower temperatures, most likely owing to a lower degree of water, but we 
found that the decomposition temperatures are only slightly increased (Figure 3a). Similarly, the 
less hygroscopic 10k L-PEI shows an unchanged thermal degradation profile relative to its 
crosslinked derivatives (Figure 3b).  Surprisingly, the percentage of crosslinker did not seem to 
affect the thermal stability in either case, with all crosslinked materials yielding a thermal 
decomposition of 300 °C. Additionally, there was no Tg evident in any of the crosslinked 
materials (SI Figure 1). Thus, while cyclopropenium-mediated crosslinking of PEI chains 
dramatically changes solubility, thermal stability only slightly increases.  
Though they do not have high processability in the solid state, the crosslinked PEI 
polymers can be dispersed as stable nanoparticles in aqueous media and exhibit a permanent 
positive charge, characteristic of the cyclopropenium moiety. We used dynamic light scattering 
to determine the hydrodynamic diameter (DH) and zeta potential (ζ) of all crosslinked polymers 
(Table 1). All measured particles show a size ca. 200 nm with a highly positive surface charge. 
The trisaminocyclopropenium cation, stabilized both by aromaticity and resonance, is uniquely a 
permanent positive charge, stable across a wide pH range. To test whether our high zeta 
potentials were due to the cyclopropenium crosslinker or protonated secondary amines on the 
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PEI backbone, we basified our materials with 1M NaOH and remeasured their surface potential. 
Indeed, all L-PEI crosslinked materials maintained a positive zeta potential even in strongly 
Figure 3. Thermal gravimetric analysis of crosslinked polymers. 
Cyclopropenium crosslinking of 25k L-PEI (a) and 10k L-PEI (b) minimally 
changes thermal decomposition temperature. There is no change in thermal 
decomposition with increased crosslinking density. 
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basic conditions. Thus, the stable cationic charge characteristic of the L-PEI crosslinked 
materials derives from pH-stable cyclopropenium units.  
Table 1. Size and surface charge of crosslinked L-PEI nanoparticles. 
In order to confirm the size and shape of these nanoparticles, we performed transmission 
electron microscopy (TEM). The TEM measurements corroborated our DLS results: these 
crosslinked PEI polymers form nanoparticles in solution, approximately 200 nm in diameter 
(Figure 4). Furthermore, TEM revealed that these nanoparticles are spherical, which represents 
the first time PEI has been crosslinked into nanoparticles in one step, at ambient temperature, 
without purification.  
Finally, to explore the modularity of this synthetic strategy, we performed the 
cyclopropenium-mediated crosslinking on two additional polymers containing secondary amines, 
namely branched PEI (B-PEI) and poly(methylaminostyrene) (PMAS).  While all the secondary 
amines in PEI are found in the main chain, PMAS contains pendent secondary amines, and B-PEI 
is composed of approximately 25% primary amines and 25% tertiary amines.11 For B-PEI, we 
were only able to isolate nanoparticles when the crosslinking was performed with 30 mol% 
pentachlorocyclopropane (SI Figure 2). Furthermore, the B-PEI crosslinked materials showed a 
marked decrease in surface charge, suggesting a higher degree of unreacted amines that would be 
MW Mol% Crosslinker DH (nm) ζ Potential (mV) ζ Potential at pH 14 (mV) 
L-PEI 25k 
30% 145 ± 10 45 ± 4 4 ± 1 
10% 179 ± 3 43 ± 6 3 ± 1 
5% 203 ± 9 27 ± 5 9 ± 2 
L-PEI 10k 
30% 105 ± 3 25 ± 6 2 ± 0.5 
10% 82 ± 6 20 ± 4 2 ± 0.5 
5% 90 ± 3 22 ± 6 4 ± 2 
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neutrally charged at basic pH (SI Table 1). As primary amines can ring open 
pentachlorocyclopropane to an allyl cation rather than form cyclopropenium,28 these data may be 
a result of a lower degree of cyclopropenium crosslinkers. For PMAS, we found that crosslinking 
with cyclopropenium led to insoluble polymers that could not be dissolved nor dispersed in any 
solvent. While the reduced solubility suggested successful crosslinking and the materials 
demonstrated high thermal stability (SI Figure 3), we were unable to disperse these materials in 
aqueous media to form nanoparticles. We hypothesize that this is due to the high hydrophobicity 
of the parent polymer. These results suggest it will be important for future cyclopropenium-
mediated crosslinking work to avoid the presence of primary amines and limit hydrophobicity to 
ensure the synthesis of stable cationic crosslinked nanoparticles.  
Figure 4. Transmission electron micrograph of cyclopropenium-
crosslinked 25k L-PEI. 
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In conclusion, we have shown that polymers containing secondary amines can be rapidly 
crosslinked with cyclopropenium in one step, at ambient temperature, and without purification to 
form nanoparticles with high thermal stability and a permanent positive charge. The spherical 
nanoparticles are of discrete size and maintain their positive charge in strongly alkaline solutions 
due to their stable cyclopropenium linkages. The crosslinkers can be rapidly formed from the 
addition of either pentachlorocyclopropane or tetrachlorocyclopropene to a solution of any 
polymer containing secondary amines. This strategy will enable the synthesis of novel structures 
comprising cyclopropenium, permitting the incorporation of this smallest Hückel aromatic ring 
into fully conjugated materials. Furthermore, the planarity and C3 symmetry of cyclopropenium 
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All materials were purchased from Sigma-Aldrich and were used without further purification 
except for pentachlorocyclopropane and poly(methylaminostyrene) which were synthesized 
according to previously reported procedures. [Refs. #24 and 25] 
 
Characterization 
13C NMR spectra were recorded in MeOD on a Bruker Avance III 500 spectrometer. IR spectra 
were recorded on a Perkin Elmer Spectrum Two FT-IR spectrometer. Thermal gravimetric analysis 
was performed on a TA Instruments Q500 from 50 to 700 °C at a ramp rate of 5 °C min-1 under a 
nitrogen atmosphere. Differential scanning calorimetry was performed on a TA Instruments 
Q2000 fitted with a RCS90 refrigerated cooling system. DSC measurements were taken at a 
sampling rate of 10 °C min-1 in the temperature range of 0 °C to 200 °C.  
Hydrodynamic diameter and zeta potential were measured on a Malvern Zetasizer Nano ZS. 
Crosslinked polymers were dispersed in H2O and diluted to a concentration of 0.1 mg / mL. Tween 
80 was added to the 25k L-PEI crosslinked polymers as a stabilizer so that the polymer solution 
contained a 1:100 w/w ratio of Tween 80:Polymer. For measurements at basic conditions, 1M 
NaOH was added dropwise to the polymer solution until a pH of 14 was achieved. The reported 
diameters are the average of three measurements, where each measurement comprises at least 10 
acquisitions. The zeta potentials were calculated according to the Smoluchowski approximation. 
Nanoparticles were analyzed on a Jeol (Jem-1400Plus equipped with Gatan Orius SC 600 camera) 
transmission electron microscopy using negative staining. Briefly, 5 µl of sample in water was 
placed on formvar/carbon coated copper grids (200 mesh, EMS), mixed with 5 µl of uranyl acetate 
(2%) for ~10 sec, excess mix of sample and stain was gently absorbed and grids were air-dried. 
 
General Crosslinking Procedure 
Pentachlorocyclopropane or tetrachlorocyclopropene (10-30 mol%) were added dropwise to a 0.5 
mM solution of PEI in CHCl3 at 0 °C. A white precipitate formed instantly and the reaction was 





Supplementary Tables and Figures 
Table S1. Size and surface charge of crosslinked B-PEI nanoparticles 
MW Mol% Crosslinker DH (nm) ζ Potential (mV) ζ Potential at pH 14 (mV) 





Figure S1. Differential scanning calorimetry of 10k L-PEI crosslinked polymers.  
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Figure S2. Transmission electron micrograph of cyclopropenium-crosslinked branched-PEI 1.3k 
Figure S3. Thermal gravimetric analysis of poly(methylaminostyrene) crosslinked polymers. 
There is no change in thermal decomposition with increased crosslinking density.  
